DRREDDY - Dr. Reddy's Laboratories Limited
Dr. Reddy's Laboratories Limited Share Market Related News
-: Stock News :- DRREDDY 16-06-2022 To 16-06-2022
✔️ LIC increases stake in Dr Reddy's
✔️ LIC ups stake in Dr Reddy's to 5.6 per cent
-: Stock News :- DRREDDY 14-06-2022 To 16-06-2022
✔️ Dr. Reddy's launches Nexavar generic in the US
✔️ LIC ups stake in Dr Reddy's to 5.6 per cent
-: Stock News :- DRREDDY 13-06-2022 To 16-06-2022
✔️ Top 10 trading ideas from experts for next 3-4 weeks as bears maul the markets
✔️ LIC ups stake in Dr Reddy's to 5.6 per cent
-: Stock News :- DRREDDY 10-06-2022 To 09-06-2022
✔️ Dr Reddy's arm inks pact with US-based Olema Pharmaceuticals
✔️ Dr Reddy's subsidiary inks pact with US-based Olema Pharmaceuticals
-: Stock News :- DRREDDY 07-06-2022 To 09-06-2022
✔️ Why the fall in Dr Reddy's stock today is unwarranted
✔️ Dr Reddy's subsidiary inks pact with US-based Olema Pharmaceuticals
-: Stock News :- DRREDDY 28-05-2022 To 09-06-2022
✔️ Dr Reddy's launches Pemetrexed injection in US
✔️ Dr Reddy's subsidiary inks pact with US-based Olema Pharmaceuticals
-: Stock News :- DRREDDY 25-05-2022 To 09-06-2022
✔️ Dr. Reddy's, Senores Pharmaceuticals launch Ketorolac Tromethamine tablets in US
✔️ Dr Reddy's subsidiary inks pact with US-based Olema Pharmaceuticals
-: Stock News :- DRREDDY 24-05-2022 To 09-06-2022
✔️ Buy Dr. Reddy's Laboratories; target of Rs 5261: KR Choksey
✔️ Dr Reddy's subsidiary inks pact with US-based Olema Pharmaceuticals
-: Stock News :- DRREDDY 22-05-2022 To 09-06-2022
✔️ Launches, base biz expansion tonic for Dr Reddy's double-digit growth
✔️ Dr Reddy's subsidiary inks pact with US-based Olema Pharmaceuticals
-: Stock News :- DRREDDY 21-05-2022 To 21-05-2022
✔️ Buy Dr Reddy's Laboratories; target of Rs 4800: ICICI Direct
✔️ Buy Dr. Reddy's Laboratories: target of Rs 5550: Sharekhan
✔️ Buy Dr Reddy's Labs; target of Rs 4800: Motilal Oswal
-: Stock News :- DRREDDY 20-05-2022 To 19-05-2022
✔️ Dr Reddy's sees sharpest intra-day rally since Sept 2020; stock surges 8%
✔️ As Dr Reddy's rises after earnings, should you buy or sell stock?
✔️ Dr Reddy'sQ4 net down 76% at 88 crore
✔️ Dr Reddy's Lab to approach regulator for Sputnik Light as booster dose
✔️ Dr Reddy's Labs Q4 PAT falls 76% on pricing pressure, low export benefit
✔️ Dr Reddy'sQ4 net profit down 76% at 88 crore
✔️ Impairment hit: Dr Reddy's net profit declines 76% to Rs 88 cr in Q4
✔️ Dr Reddy's Q4 PAT falls 76% YoY on impairment costs; misses estimates
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
-: Stock News :- DRREDDY 11-05-2022 To 19-05-2022
✔️ Dr Reddy's inks pact with South Korean drug firm HK inno.N Corporation
✔️ Dr. Reddy's, South Korean firm partner for gastric diseases drug
✔️ Dr Reddy'sQ4 net down 76% at 88 crore
✔️ Dr Reddy's Lab to approach regulator for Sputnik Light as booster dose
✔️ Dr Reddy's Labs Q4 PAT falls 76% on pricing pressure, low export benefit
✔️ Dr Reddy'sQ4 net profit down 76% at 88 crore
✔️ Impairment hit: Dr Reddy's net profit declines 76% to Rs 88 cr in Q4
✔️ Dr Reddy's Q4 PAT falls 76% YoY on impairment costs; misses estimates
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
-: Stock News :- DRREDDY 21-04-2022 To 19-05-2022
✔️ Dr Reddy's launchesPosaconazoletablets in US
✔️ Dr. Reddy's, South Korean firm partner for gastric diseases drug
✔️ Dr Reddy'sQ4 net down 76% at 88 crore
✔️ Dr Reddy's Lab to approach regulator for Sputnik Light as booster dose
✔️ Dr Reddy's Labs Q4 PAT falls 76% on pricing pressure, low export benefit
✔️ Dr Reddy'sQ4 net profit down 76% at 88 crore
✔️ Impairment hit: Dr Reddy's net profit declines 76% to Rs 88 cr in Q4
✔️ Dr Reddy's Q4 PAT falls 76% YoY on impairment costs; misses estimates
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
-: Stock News :- DRREDDY 12-04-2022 To 19-05-2022
✔️ Buy Dr. Reddy's Laboratories: target of Rs 5550: Sharekhan
✔️ Dr. Reddy's, South Korean firm partner for gastric diseases drug
✔️ Dr Reddy'sQ4 net down 76% at 88 crore
✔️ Dr Reddy's Lab to approach regulator for Sputnik Light as booster dose
✔️ Dr Reddy's Labs Q4 PAT falls 76% on pricing pressure, low export benefit
✔️ Dr Reddy'sQ4 net profit down 76% at 88 crore
✔️ Impairment hit: Dr Reddy's net profit declines 76% to Rs 88 cr in Q4
✔️ Dr Reddy's Q4 PAT falls 76% YoY on impairment costs; misses estimates
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
-: Stock News :- DRREDDY 05-04-2022 To 19-05-2022
✔️ Dr Reddy's launches new generic injection in US market
✔️ Dr Reddy's launches generic Methylprednisolone Sodium Succinate for injection in US
✔️ Dr Reddy'sQ4 net down 76% at 88 crore
✔️ Dr Reddy's Lab to approach regulator for Sputnik Light as booster dose
✔️ Dr Reddy's Labs Q4 PAT falls 76% on pricing pressure, low export benefit
✔️ Dr Reddy'sQ4 net profit down 76% at 88 crore
✔️ Impairment hit: Dr Reddy's net profit declines 76% to Rs 88 cr in Q4
✔️ Dr Reddy's Q4 PAT falls 76% YoY on impairment costs; misses estimates
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
-: Stock News :- DRREDDY 01-04-2022 To 19-05-2022
✔️ Dr Reddy inks $61-mn deal to acquire Cidmus brand in India from Novartis
✔️ Dr Reddy's launches generic Methylprednisolone Sodium Succinate for injection in US
✔️ Dr Reddy'sQ4 net down 76% at 88 crore
✔️ Dr Reddy's Lab to approach regulator for Sputnik Light as booster dose
✔️ Dr Reddy's Labs Q4 PAT falls 76% on pricing pressure, low export benefit
✔️ Dr Reddy'sQ4 net profit down 76% at 88 crore
✔️ Impairment hit: Dr Reddy's net profit declines 76% to Rs 88 cr in Q4
✔️ Dr Reddy's Q4 PAT falls 76% YoY on impairment costs; misses estimates
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
-: Stock News :- DRREDDY 01-03-2022 To 19-05-2022
✔️ Valuations turning attractive for Dr Reddy's as company outperforms sector
✔️ Dr Reddy's launches generic Methylprednisolone Sodium Succinate for injection in US
✔️ Dr Reddy'sQ4 net down 76% at 88 crore
✔️ Dr Reddy's Lab to approach regulator for Sputnik Light as booster dose
✔️ Dr Reddy's Labs Q4 PAT falls 76% on pricing pressure, low export benefit
✔️ Dr Reddy'sQ4 net profit down 76% at 88 crore
✔️ Impairment hit: Dr Reddy's net profit declines 76% to Rs 88 cr in Q4
✔️ Dr Reddy's Q4 PAT falls 76% YoY on impairment costs; misses estimates
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
-: Stock News :- DRREDDY 24-02-2022 To 19-05-2022
✔️ Dr Reddy's falls 3%, hits 52-week low; stock slips 10% in one month
✔️ Dr Reddy's launches generic Methylprednisolone Sodium Succinate for injection in US
✔️ Dr Reddy'sQ4 net down 76% at 88 crore
✔️ Dr Reddy's Lab to approach regulator for Sputnik Light as booster dose
✔️ Dr Reddy's Labs Q4 PAT falls 76% on pricing pressure, low export benefit
✔️ Dr Reddy'sQ4 net profit down 76% at 88 crore
✔️ Impairment hit: Dr Reddy's net profit declines 76% to Rs 88 cr in Q4
✔️ Dr Reddy's Q4 PAT falls 76% YoY on impairment costs; misses estimates
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
-: Stock News :- DRREDDY 21-02-2022 To 19-05-2022
✔️ Binnopharm to acquire 2 anti-bacterial brands from Dr Reddy's
✔️ Dr Reddy's Laboratories gains 2% on selling of two anti-bacterial brands
✔️ Dr Reddy'sQ4 net down 76% at 88 crore
✔️ Dr Reddy's Lab to approach regulator for Sputnik Light as booster dose
✔️ Dr Reddy's Labs Q4 PAT falls 76% on pricing pressure, low export benefit
✔️ Dr Reddy'sQ4 net profit down 76% at 88 crore
✔️ Impairment hit: Dr Reddy's net profit declines 76% to Rs 88 cr in Q4
✔️ Dr Reddy's Q4 PAT falls 76% YoY on impairment costs; misses estimates
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
-: Stock News :- DRREDDY 16-02-2022 To 19-05-2022
✔️ Mankind Pharma acquires two derma and respiratory brands from Dr Reddy's
✔️ Mankind Pharma to acquire Combihale and Daffy brands from Dr Reddy's Labs
✔️ Mankind Pharma to acquire two brands from Dr Reddy's Laboratories
✔️ Dr Reddy's Lab to approach regulator for Sputnik Light as booster dose
✔️ Dr Reddy's Labs Q4 PAT falls 76% on pricing pressure, low export benefit
✔️ Dr Reddy'sQ4 net profit down 76% at 88 crore
✔️ Impairment hit: Dr Reddy's net profit declines 76% to Rs 88 cr in Q4
✔️ Dr Reddy's Q4 PAT falls 76% YoY on impairment costs; misses estimates
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
-: Stock News :- DRREDDY 11-02-2022 To 19-05-2022
✔️ Dr Reddy's Laboratories inks exclusive sales pact with Novartis India
✔️ Mankind Pharma to acquire Combihale and Daffy brands from Dr Reddy's Labs
✔️ Mankind Pharma to acquire two brands from Dr Reddy's Laboratories
✔️ Dr Reddy's Lab to approach regulator for Sputnik Light as booster dose
✔️ Dr Reddy's Labs Q4 PAT falls 76% on pricing pressure, low export benefit
✔️ Dr Reddy'sQ4 net profit down 76% at 88 crore
✔️ Impairment hit: Dr Reddy's net profit declines 76% to Rs 88 cr in Q4
✔️ Dr Reddy's Q4 PAT falls 76% YoY on impairment costs; misses estimates
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
-: Stock News :- DRREDDY 09-02-2022 To 19-05-2022
✔️ Dr Reddy's Laboratories launches generic drug in the US market
✔️ Mankind Pharma to acquire Combihale and Daffy brands from Dr Reddy's Labs
✔️ Mankind Pharma to acquire two brands from Dr Reddy's Laboratories
✔️ Dr Reddy's Lab to approach regulator for Sputnik Light as booster dose
✔️ Dr Reddy's Labs Q4 PAT falls 76% on pricing pressure, low export benefit
✔️ Dr Reddy'sQ4 net profit down 76% at 88 crore
✔️ Impairment hit: Dr Reddy's net profit declines 76% to Rs 88 cr in Q4
✔️ Dr Reddy's Q4 PAT falls 76% YoY on impairment costs; misses estimates
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
-: Stock News :- DRREDDY 08-02-2022 To 19-05-2022
✔️ Covid-19 vaccine: Hospitals see no immediate rush for Sputnik Light
✔️ Mankind Pharma to acquire Combihale and Daffy brands from Dr Reddy's Labs
✔️ Mankind Pharma to acquire two brands from Dr Reddy's Laboratories
✔️ Dr Reddy's Lab to approach regulator for Sputnik Light as booster dose
✔️ Dr Reddy's Labs Q4 PAT falls 76% on pricing pressure, low export benefit
✔️ Dr Reddy'sQ4 net profit down 76% at 88 crore
✔️ Impairment hit: Dr Reddy's net profit declines 76% to Rs 88 cr in Q4
✔️ Dr Reddy's Q4 PAT falls 76% YoY on impairment costs; misses estimates
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
-: Stock News :- DRREDDY 06-02-2022 To 19-05-2022
✔️ Submitted proposal to test Sputnik Light as Covid booster dose: Dr Reddy's
✔️ Mankind Pharma to acquire Combihale and Daffy brands from Dr Reddy's Labs
✔️ Mankind Pharma to acquire two brands from Dr Reddy's Laboratories
✔️ Dr Reddy's Lab to approach regulator for Sputnik Light as booster dose
✔️ Dr Reddy's Labs Q4 PAT falls 76% on pricing pressure, low export benefit
✔️ Dr Reddy'sQ4 net profit down 76% at 88 crore
✔️ Impairment hit: Dr Reddy's net profit declines 76% to Rs 88 cr in Q4
✔️ Dr Reddy's Q4 PAT falls 76% YoY on impairment costs; misses estimates
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
-: Stock News :- DRREDDY 03-02-2022 To 19-05-2022
✔️ Dr Reddy's Laboratories inks agreement to acquire Nimbus Health GmbH
✔️ Dr Reddy's to acquire German medical cannabis firm Nimbus Health
✔️ Mankind Pharma to acquire two brands from Dr Reddy's Laboratories
✔️ Dr Reddy's Lab to approach regulator for Sputnik Light as booster dose
✔️ Dr Reddy's Labs Q4 PAT falls 76% on pricing pressure, low export benefit
✔️ Dr Reddy'sQ4 net profit down 76% at 88 crore
✔️ Impairment hit: Dr Reddy's net profit declines 76% to Rs 88 cr in Q4
✔️ Dr Reddy's Q4 PAT falls 76% YoY on impairment costs; misses estimates
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
-: Stock News :- DRREDDY 01-02-2022 To 19-05-2022
✔️ Buy Dr Reddy's Labs; target of Rs 5160: Motilal Oswal
✔️ Buy Dr Reddys Laboratories; target of Rs 5160: ICICI Direct
✔️ Mankind Pharma to acquire two brands from Dr Reddy's Laboratories
✔️ Dr Reddy's Lab to approach regulator for Sputnik Light as booster dose
✔️ Dr Reddy's Labs Q4 PAT falls 76% on pricing pressure, low export benefit
✔️ Dr Reddy'sQ4 net profit down 76% at 88 crore
✔️ Impairment hit: Dr Reddy's net profit declines 76% to Rs 88 cr in Q4
✔️ Dr Reddy's Q4 PAT falls 76% YoY on impairment costs; misses estimates
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
-: Stock News :- DRREDDY 31-01-2022 To 19-05-2022
✔️ Dr Reddy's: Supported by traction in limited competition products
✔️ Pricing trend, launches, stability of growth boosters for Dr Reddy's
✔️ Mankind Pharma to acquire two brands from Dr Reddy's Laboratories
✔️ Dr Reddy's Lab to approach regulator for Sputnik Light as booster dose
✔️ Dr Reddy's Labs Q4 PAT falls 76% on pricing pressure, low export benefit
✔️ Dr Reddy'sQ4 net profit down 76% at 88 crore
✔️ Impairment hit: Dr Reddy's net profit declines 76% to Rs 88 cr in Q4
✔️ Dr Reddy's Q4 PAT falls 76% YoY on impairment costs; misses estimates
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
-: Stock News :- DRREDDY 28-01-2022 To 19-05-2022
✔️ Q3FY22 Quarterly Result Announced for Dr. Reddy's Laboratories Ltd.
✔️ Dr Reddy's Lab Q3 results: Net profit soars over 25 times to Rs 707 cr
✔️ Mankind Pharma to acquire two brands from Dr Reddy's Laboratories
✔️ Dr Reddy's Lab to approach regulator for Sputnik Light as booster dose
✔️ Dr Reddy's Labs Q4 PAT falls 76% on pricing pressure, low export benefit
✔️ Dr Reddy'sQ4 net profit down 76% at 88 crore
✔️ Impairment hit: Dr Reddy's net profit declines 76% to Rs 88 cr in Q4
✔️ Dr Reddy's Q4 PAT falls 76% YoY on impairment costs; misses estimates
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
-: Stock News :- DRREDDY 06-01-2022 To 19-05-2022
✔️ UoH, Dr Reddy's join hands to develop blockchain solutions for pharma industry
✔️ Dr Reddy's Lab Q3 results: Net profit soars over 25 times to Rs 707 cr
✔️ Mankind Pharma to acquire two brands from Dr Reddy's Laboratories
✔️ Dr Reddy's Lab to approach regulator for Sputnik Light as booster dose
✔️ Dr Reddy's Labs Q4 PAT falls 76% on pricing pressure, low export benefit
✔️ Dr Reddy'sQ4 net profit down 76% at 88 crore
✔️ Impairment hit: Dr Reddy's net profit declines 76% to Rs 88 cr in Q4
✔️ Dr Reddy's Q4 PAT falls 76% YoY on impairment costs; misses estimates
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
-: Stock News :- DRREDDY 04-01-2022 To 19-05-2022
✔️ Dr Reddy's introduces anti-COVID drug molnupiravir at Rs 35 per capsule
✔️ Dr Reddy's to launch molnupiravir next week at 35 per capsule
✔️ Dr Reddy's to launch Molflu at Rs 35 per capsule for Covid treatment
✔️ Dr Reddy's to launch generic Covid Merck pill at 35/capsule
✔️ Dr Reddy's Labs Q4 PAT falls 76% on pricing pressure, low export benefit
✔️ Dr Reddy'sQ4 net profit down 76% at 88 crore
✔️ Impairment hit: Dr Reddy's net profit declines 76% to Rs 88 cr in Q4
✔️ Dr Reddy's Q4 PAT falls 76% YoY on impairment costs; misses estimates
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
-: Stock News :- DRREDDY 28-12-2021 To 19-05-2022
✔️ Dr Reddy's gets DCGI nod for Molnupiravir, to launch soon
✔️ Dr Reddy's Laboratories to introduce Molnupiravir to treat Covid-19 shortly
✔️ Dr Reddy's to launch Molflu at Rs 35 per capsule for Covid treatment
✔️ Dr Reddy's to launch generic Covid Merck pill at 35/capsule
✔️ Dr Reddy's Labs Q4 PAT falls 76% on pricing pressure, low export benefit
✔️ Dr Reddy'sQ4 net profit down 76% at 88 crore
✔️ Impairment hit: Dr Reddy's net profit declines 76% to Rs 88 cr in Q4
✔️ Dr Reddy's Q4 PAT falls 76% YoY on impairment costs; misses estimates
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
-: Stock News :- DRREDDY 27-12-2021 To 19-05-2022
✔️ Buy Dr. Reddy's Laboratories: target of Rs 5900: Sharekhan
✔️ Dr Reddy's Laboratories to introduce Molnupiravir to treat Covid-19 shortly
✔️ Dr Reddy's to launch Molflu at Rs 35 per capsule for Covid treatment
✔️ Dr Reddy's to launch generic Covid Merck pill at 35/capsule
✔️ Dr Reddy's Labs Q4 PAT falls 76% on pricing pressure, low export benefit
✔️ Dr Reddy'sQ4 net profit down 76% at 88 crore
✔️ Impairment hit: Dr Reddy's net profit declines 76% to Rs 88 cr in Q4
✔️ Dr Reddy's Q4 PAT falls 76% YoY on impairment costs; misses estimates
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
-: Stock News :- DRREDDY 13-12-2021 To 19-05-2022
✔️ Dr Reddy's may underperform over concerns about launch of complex products
✔️ Dr Reddy's Laboratories to introduce Molnupiravir to treat Covid-19 shortly
✔️ Dr Reddy's to launch Molflu at Rs 35 per capsule for Covid treatment
✔️ Dr Reddy's to launch generic Covid Merck pill at 35/capsule
✔️ Dr Reddy's Labs Q4 PAT falls 76% on pricing pressure, low export benefit
✔️ Dr Reddy'sQ4 net profit down 76% at 88 crore
✔️ Impairment hit: Dr Reddy's net profit declines 76% to Rs 88 cr in Q4
✔️ Dr Reddy's Q4 PAT falls 76% YoY on impairment costs; misses estimates
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
-: Stock News :- DRREDDY 10-12-2021 To 19-05-2022
✔️ India stock markets seen volatile; Paytm, Dr Reddy's in focus
✔️ Dr Reddy's Laboratories seeks DCGI's nod for phase-3 trial of Sputnik Light as booster dose
✔️ Dr Reddy's seeks nod for phase-3 trial of Sputnik Light as booster dose
✔️ Dr Reddy's launches Valsartan tablets to treat high blood pressure, heart failure in the US
✔️ Dr Reddy's launches Valsartan tablets in US
✔️ Dr Reddy's launches drug in US to treat high blood pressure, heart failure
✔️ Dr. Reddy's inks pact with Singapore firm to sell Trastuzumab biosimilar
✔️ Indian Covid vaccine makers bank on boosters as demand crashes
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
-: Stock News :- DRREDDY 06-12-2021 To 19-05-2022
✔️ The shadow of Form 483 over Dr Reddy's stock
✔️ Dr Reddy's Laboratories seeks DCGI's nod for phase-3 trial of Sputnik Light as booster dose
✔️ Dr Reddy's seeks nod for phase-3 trial of Sputnik Light as booster dose
✔️ Dr Reddy's launches Valsartan tablets to treat high blood pressure, heart failure in the US
✔️ Dr Reddy's launches Valsartan tablets in US
✔️ Dr Reddy's launches drug in US to treat high blood pressure, heart failure
✔️ Dr. Reddy's inks pact with Singapore firm to sell Trastuzumab biosimilar
✔️ Indian Covid vaccine makers bank on boosters as demand crashes
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
-: Stock News :- DRREDDY 29-11-2021 To 19-05-2022
✔️ Dr Reddy's eyes Sputnik vaccine exports after domestic struggle
✔️ Covid: Dr Reddy's eyes Sputnik vaccine exports after domestic struggle
✔️ Dr Reddy's seeks nod for phase-3 trial of Sputnik Light as booster dose
✔️ Dr Reddy's launches Valsartan tablets to treat high blood pressure, heart failure in the US
✔️ Dr Reddy's launches Valsartan tablets in US
✔️ Dr Reddy's launches drug in US to treat high blood pressure, heart failure
✔️ Dr. Reddy's inks pact with Singapore firm to sell Trastuzumab biosimilar
✔️ Indian Covid vaccine makers bank on boosters as demand crashes
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
-: Stock News :- DRREDDY 09-11-2021 To 19-05-2022
✔️ Dr Reddys Labs Standalone September 2021 Net Sales at Rs 3,823.40 crore, up 14.27% Y-o-Y
✔️ Covid: Dr Reddy's eyes Sputnik vaccine exports after domestic struggle
✔️ Dr Reddy's seeks nod for phase-3 trial of Sputnik Light as booster dose
✔️ Dr Reddy's launches Valsartan tablets to treat high blood pressure, heart failure in the US
✔️ Dr Reddy's launches Valsartan tablets in US
✔️ Dr Reddy's launches drug in US to treat high blood pressure, heart failure
✔️ Dr. Reddy's inks pact with Singapore firm to sell Trastuzumab biosimilar
✔️ Indian Covid vaccine makers bank on boosters as demand crashes
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
-: Stock News :- DRREDDY 03-11-2021 To 19-05-2022
✔️ Buy Dr Reddy's Labs; target of Rs 5470: Motilal Oswal
✔️ Covid: Dr Reddy's eyes Sputnik vaccine exports after domestic struggle
✔️ Dr Reddy's seeks nod for phase-3 trial of Sputnik Light as booster dose
✔️ Dr Reddy's launches Valsartan tablets to treat high blood pressure, heart failure in the US
✔️ Dr Reddy's launches Valsartan tablets in US
✔️ Dr Reddy's launches drug in US to treat high blood pressure, heart failure
✔️ Dr. Reddy's inks pact with Singapore firm to sell Trastuzumab biosimilar
✔️ Indian Covid vaccine makers bank on boosters as demand crashes
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
-: Stock News :- DRREDDY 01-11-2021 To 19-05-2022
✔️ Dr Reddy's: Aced by emerging markets growth
✔️ What should investors do with Dr Reddy's Laboratories post Q2 results; Buy, sell or hold?
✔️ India, EMs provide a shot in the arm for Dr Reddy's
✔️ Dr Reddy's launches Valsartan tablets to treat high blood pressure, heart failure in the US
✔️ Dr Reddy's launches Valsartan tablets in US
✔️ Dr Reddy's launches drug in US to treat high blood pressure, heart failure
✔️ Dr. Reddy's inks pact with Singapore firm to sell Trastuzumab biosimilar
✔️ Indian Covid vaccine makers bank on boosters as demand crashes
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
-: Stock News :- DRREDDY 29-10-2021 To 19-05-2022
✔️ Dr Reddy's Net Profit Rises 30% To Rs 992 Crore In September Quarter
✔️ Dr Reddy's Laboratories working on enhancing Covid-19 portfolio
✔️ Dr Reddy's to begin trial of paediatric Sputnik V, booster dose in November
✔️ Dr Reddy's Laboratories Q2 net profit up 30% at 992 crore
✔️ Dr Reddy's profit rises 30% to Rs 992 crore, revenue rises by 18% to Rs 5,763 crore in Q2
✔️ Dr Reddys Labs gains 7% as profit grows 30% YoY in Q2, margins expand
✔️ Dr Reddy's Q2 profit rises 30% to 992 cr; stock up 6%
✔️ Dr Reddy's Q2 Results Preview: Revenue expected to increase 4-5%, PAT to decline 15%
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
-: Stock News :- DRREDDY 26-10-2021 To 19-05-2022
✔️ Boehringer Ingelheim, Indian pharma in legal battle over diabetes drug
✔️ Dr Reddy's Laboratories working on enhancing Covid-19 portfolio
✔️ Dr Reddy's to begin trial of paediatric Sputnik V, booster dose in November
✔️ Dr Reddy's Laboratories Q2 net profit up 30% at 992 crore
✔️ Dr Reddy's profit rises 30% to Rs 992 crore, revenue rises by 18% to Rs 5,763 crore in Q2
✔️ Dr Reddys Labs gains 7% as profit grows 30% YoY in Q2, margins expand
✔️ Dr Reddy's Q2 profit rises 30% to 992 cr; stock up 6%
✔️ Dr Reddy's Q2 Results Preview: Revenue expected to increase 4-5%, PAT to decline 15%
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
-: Stock News :- DRREDDY 19-10-2021 To 19-05-2022
✔️ Dr Reddy's Lab receives USFDA approval to market Lenalidomide capsule
✔️ Dr Reddy's Lab receives USFDA approval to market Lenalidomide capsule
✔️ Dr Reddy's gets FDA nod for generic Revlimid; Enjoys 180 days exclusivity
✔️ Dr. Reddy's gets approval for Lenalidomide Capsules from US FDA
✔️ Dr Reddy's profit rises 30% to Rs 992 crore, revenue rises by 18% to Rs 5,763 crore in Q2
✔️ Dr Reddys Labs gains 7% as profit grows 30% YoY in Q2, margins expand
✔️ Dr Reddy's Q2 profit rises 30% to 992 cr; stock up 6%
✔️ Dr Reddy's Q2 Results Preview: Revenue expected to increase 4-5%, PAT to decline 15%
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
-: Stock News :- DRREDDY 14-10-2021 To 19-05-2022
✔️ Dr Reddy's launches an anti-cancer drug in China
✔️ Dr Reddy's Lab receives USFDA approval to market Lenalidomide capsule
✔️ Dr Reddy's gets FDA nod for generic Revlimid; Enjoys 180 days exclusivity
✔️ Dr. Reddy's gets approval for Lenalidomide Capsules from US FDA
✔️ Dr Reddy's profit rises 30% to Rs 992 crore, revenue rises by 18% to Rs 5,763 crore in Q2
✔️ Dr Reddys Labs gains 7% as profit grows 30% YoY in Q2, margins expand
✔️ Dr Reddy's Q2 profit rises 30% to 992 cr; stock up 6%
✔️ Dr Reddy's Q2 Results Preview: Revenue expected to increase 4-5%, PAT to decline 15%
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
-: Stock News :- DRREDDY 13-10-2021 To 19-05-2022
✔️ Dr Reddy's, Ipca among outperformers in pharma market in September
✔️ Dr Reddy's Lab receives USFDA approval to market Lenalidomide capsule
✔️ Dr Reddy's gets FDA nod for generic Revlimid; Enjoys 180 days exclusivity
✔️ Dr. Reddy's gets approval for Lenalidomide Capsules from US FDA
✔️ Dr Reddy's profit rises 30% to Rs 992 crore, revenue rises by 18% to Rs 5,763 crore in Q2
✔️ Dr Reddys Labs gains 7% as profit grows 30% YoY in Q2, margins expand
✔️ Dr Reddy's Q2 profit rises 30% to 992 cr; stock up 6%
✔️ Dr Reddy's Q2 Results Preview: Revenue expected to increase 4-5%, PAT to decline 15%
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
-: Stock News :- DRREDDY 10-10-2021 To 19-05-2022
✔️ Tech Query: Can I hold Dr. Reddy's stock for two years?
✔️ Dr Reddy's Lab receives USFDA approval to market Lenalidomide capsule
✔️ Dr Reddy's gets FDA nod for generic Revlimid; Enjoys 180 days exclusivity
✔️ Dr. Reddy's gets approval for Lenalidomide Capsules from US FDA
✔️ Dr Reddy's profit rises 30% to Rs 992 crore, revenue rises by 18% to Rs 5,763 crore in Q2
✔️ Dr Reddys Labs gains 7% as profit grows 30% YoY in Q2, margins expand
✔️ Dr Reddy's Q2 profit rises 30% to 992 cr; stock up 6%
✔️ Dr Reddy's Q2 Results Preview: Revenue expected to increase 4-5%, PAT to decline 15%
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
-: Stock News :- DRREDDY 09-10-2021 To 19-05-2022
✔️ Tech Query: Can I hold Dr. Reddy's stock for two years?
✔️ Dr Reddy's Lab receives USFDA approval to market Lenalidomide capsule
✔️ Dr Reddy's gets FDA nod for generic Revlimid; Enjoys 180 days exclusivity
✔️ Dr. Reddy's gets approval for Lenalidomide Capsules from US FDA
✔️ Dr Reddy's profit rises 30% to Rs 992 crore, revenue rises by 18% to Rs 5,763 crore in Q2
✔️ Dr Reddys Labs gains 7% as profit grows 30% YoY in Q2, margins expand
✔️ Dr Reddy's Q2 profit rises 30% to 992 cr; stock up 6%
✔️ Dr Reddy's Q2 Results Preview: Revenue expected to increase 4-5%, PAT to decline 15%
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
-: Stock News :- DRREDDY 06-10-2021 To 19-05-2022
✔️ Dr. Reddy's Laboratories Q2 PAT may dip 11.5% YoY to Rs 752.2 cr: Prabhudas Lilladher
✔️ Dr Reddy's Lab receives USFDA approval to market Lenalidomide capsule
✔️ Dr Reddy's gets FDA nod for generic Revlimid; Enjoys 180 days exclusivity
✔️ Dr. Reddy's gets approval for Lenalidomide Capsules from US FDA
✔️ Dr Reddy's profit rises 30% to Rs 992 crore, revenue rises by 18% to Rs 5,763 crore in Q2
✔️ Dr Reddys Labs gains 7% as profit grows 30% YoY in Q2, margins expand
✔️ Dr Reddy's Q2 profit rises 30% to 992 cr; stock up 6%
✔️ Dr Reddy's Q2 Results Preview: Revenue expected to increase 4-5%, PAT to decline 15%
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
-: Stock News :- DRREDDY 25-09-2021 To 19-05-2022
✔️ Why you should accumulate Dr. Reddy's Lab shares
✔️ Why you should accumulate Dr. Reddy's Lab shares
✔️ Dr Reddy's gets FDA nod for generic Revlimid; Enjoys 180 days exclusivity
✔️ Dr. Reddy's gets approval for Lenalidomide Capsules from US FDA
✔️ Dr Reddy's profit rises 30% to Rs 992 crore, revenue rises by 18% to Rs 5,763 crore in Q2
✔️ Dr Reddys Labs gains 7% as profit grows 30% YoY in Q2, margins expand
✔️ Dr Reddy's Q2 profit rises 30% to 992 cr; stock up 6%
✔️ Dr Reddy's Q2 Results Preview: Revenue expected to increase 4-5%, PAT to decline 15%
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
-: Stock News :- DRREDDY 23-09-2021 To 19-05-2022
✔️ Dr Reddy's aiming to create its own space in vaccine segment: GV Prasad
✔️ Why you should accumulate Dr. Reddy's Lab shares
✔️ Dr Reddy's gets FDA nod for generic Revlimid; Enjoys 180 days exclusivity
✔️ Dr. Reddy's gets approval for Lenalidomide Capsules from US FDA
✔️ Dr Reddy's profit rises 30% to Rs 992 crore, revenue rises by 18% to Rs 5,763 crore in Q2
✔️ Dr Reddys Labs gains 7% as profit grows 30% YoY in Q2, margins expand
✔️ Dr Reddy's Q2 profit rises 30% to 992 cr; stock up 6%
✔️ Dr Reddy's Q2 Results Preview: Revenue expected to increase 4-5%, PAT to decline 15%
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
-: Stock News :- DRREDDY 16-09-2021 To 19-05-2022
✔️ Sputnik Light single-dose vaccine launch in India may get delayed
✔️ Dr Reddy's gets nod for bridging trials of Sputnik Light vaccine
✔️ Dr Reddy's gets FDA nod for generic Revlimid; Enjoys 180 days exclusivity
✔️ Dr. Reddy's gets approval for Lenalidomide Capsules from US FDA
✔️ Dr Reddy's profit rises 30% to Rs 992 crore, revenue rises by 18% to Rs 5,763 crore in Q2
✔️ Dr Reddys Labs gains 7% as profit grows 30% YoY in Q2, margins expand
✔️ Dr Reddy's Q2 profit rises 30% to 992 cr; stock up 6%
✔️ Dr Reddy's Q2 Results Preview: Revenue expected to increase 4-5%, PAT to decline 15%
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
-: Stock News :- DRREDDY 08-09-2021 To 19-05-2022
✔️ Dr Reddy's move to exit some proprietary drugs has benefits
✔️ Dr Reddy's launches drug for women hair loss after first-ever approval in India
✔️ Dr. Reddy's launches Minoxidil for women for treatment of hair loss, secures CDSCO nod
✔️ Dr. Reddy's gets approval for Lenalidomide Capsules from US FDA
✔️ Dr Reddy's profit rises 30% to Rs 992 crore, revenue rises by 18% to Rs 5,763 crore in Q2
✔️ Dr Reddys Labs gains 7% as profit grows 30% YoY in Q2, margins expand
✔️ Dr Reddy's Q2 profit rises 30% to 992 cr; stock up 6%
✔️ Dr Reddy's Q2 Results Preview: Revenue expected to increase 4-5%, PAT to decline 15%
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
-: Stock News :- DRREDDY 07-09-2021 To 19-05-2022
✔️ Panacea Biotec supplies second component of Sputnik vaccine
✔️ Panacea Biotec supplies first shipment of Sputnik V component II developed in India
✔️ Buy Dr Reddy's Laboratories: target of Rs 5900: Sharekhan
✔️ Panacea Biotec up 9% on first shipment of second component of Sputnik V
✔️ Dr Reddy's profit rises 30% to Rs 992 crore, revenue rises by 18% to Rs 5,763 crore in Q2
✔️ Dr Reddys Labs gains 7% as profit grows 30% YoY in Q2, margins expand
✔️ Dr Reddy's Q2 profit rises 30% to 992 cr; stock up 6%
✔️ Dr Reddy's Q2 Results Preview: Revenue expected to increase 4-5%, PAT to decline 15%
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
-: Stock News :- DRREDDY 06-09-2021 To 19-05-2022
✔️ Why stock market experts are bullish on Dr. Reddy's shares? Key levels to watch
✔️ Panacea Biotec supplies first shipment of Sputnik V component II developed in India
✔️ Buy Dr Reddy's Laboratories: target of Rs 5900: Sharekhan
✔️ Panacea Biotec up 9% on first shipment of second component of Sputnik V
✔️ Dr Reddy's profit rises 30% to Rs 992 crore, revenue rises by 18% to Rs 5,763 crore in Q2
✔️ Dr Reddys Labs gains 7% as profit grows 30% YoY in Q2, margins expand
✔️ Dr Reddy's Q2 profit rises 30% to 992 cr; stock up 6%
✔️ Dr Reddy's Q2 Results Preview: Revenue expected to increase 4-5%, PAT to decline 15%
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
-: Stock News :- DRREDDY 04-09-2021 To 19-05-2022
✔️ Dr Reddy's signs pact with Citius Pharma to sell rights to anti-cancer agent
✔️ Dr Reddy's inks pact with Citius Pharma to sell rights to anti-cancer agent
✔️ Dr Reddy's inks pact with Citius Pharma to sell all rights to anti-cancer agent
✔️ Dr. Reddy's Labs signs up with Citius Pharmaceuticals
✔️ Dr Reddy's profit rises 30% to Rs 992 crore, revenue rises by 18% to Rs 5,763 crore in Q2
✔️ Dr Reddys Labs gains 7% as profit grows 30% YoY in Q2, margins expand
✔️ Dr Reddy's Q2 profit rises 30% to 992 cr; stock up 6%
✔️ Dr Reddy's Q2 Results Preview: Revenue expected to increase 4-5%, PAT to decline 15%
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
-: Stock News :- DRREDDY 02-09-2021 To 19-05-2022
✔️ Dr Reddy's Laboratories shares rise 3% on drug launch in Canada
✔️ Dr. Reddy's Canada launches generic lenalidomide
✔️ Dr Reddy's inks pact with Citius Pharma to sell all rights to anti-cancer agent
✔️ Dr. Reddy's Labs signs up with Citius Pharmaceuticals
✔️ Dr Reddy's profit rises 30% to Rs 992 crore, revenue rises by 18% to Rs 5,763 crore in Q2
✔️ Dr Reddys Labs gains 7% as profit grows 30% YoY in Q2, margins expand
✔️ Dr Reddy's Q2 profit rises 30% to 992 cr; stock up 6%
✔️ Dr Reddy's Q2 Results Preview: Revenue expected to increase 4-5%, PAT to decline 15%
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
-: Stock News :- DRREDDY 31-08-2021 To 19-05-2022
✔️ Sputnik V's production set to begin next month
✔️ Dr Reddy's launches generic version of Librax in US
✔️ Dr Reddy's Lab launches generic stomach ulcer drug in US market
✔️ Dr Reddy's launches generic stomach ulcer drug in US market
✔️ Dr Reddy's profit rises 30% to Rs 992 crore, revenue rises by 18% to Rs 5,763 crore in Q2
✔️ Dr Reddys Labs gains 7% as profit grows 30% YoY in Q2, margins expand
✔️ Dr Reddy's Q2 profit rises 30% to 992 cr; stock up 6%
✔️ Dr Reddy's Q2 Results Preview: Revenue expected to increase 4-5%, PAT to decline 15%
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
-: Stock News :- DRREDDY 29-08-2021 To 19-05-2022
✔️ Dr Reddy's Laboratories, Zydus Pharma recall products in US market
✔️ Dr Reddy's, Zydus Pharma recall products in US market
✔️ Dr Reddy's Lab launches generic stomach ulcer drug in US market
✔️ Dr Reddy's launches generic stomach ulcer drug in US market
✔️ Dr Reddy's profit rises 30% to Rs 992 crore, revenue rises by 18% to Rs 5,763 crore in Q2
✔️ Dr Reddys Labs gains 7% as profit grows 30% YoY in Q2, margins expand
✔️ Dr Reddy's Q2 profit rises 30% to 992 cr; stock up 6%
✔️ Dr Reddy's Q2 Results Preview: Revenue expected to increase 4-5%, PAT to decline 15%
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
-: Stock News :- DRREDDY 18-08-2021 To 19-05-2022
✔️ Dr Reddy’s Labs struggles in its biggest market
✔️ Dr Reddy's, Zydus Pharma recall products in US market
✔️ Dr Reddy's Lab launches generic stomach ulcer drug in US market
✔️ Dr Reddy's launches generic stomach ulcer drug in US market
✔️ Dr Reddy's profit rises 30% to Rs 992 crore, revenue rises by 18% to Rs 5,763 crore in Q2
✔️ Dr Reddys Labs gains 7% as profit grows 30% YoY in Q2, margins expand
✔️ Dr Reddy's Q2 profit rises 30% to 992 cr; stock up 6%
✔️ Dr Reddy's Q2 Results Preview: Revenue expected to increase 4-5%, PAT to decline 15%
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
-: Stock News :- DRREDDY 06-08-2021 To 19-05-2022
✔️ Mansukh Mandaviya holds meeting with Biological-E MD on progress of COVID vaccine
✔️ Dr Reddy's, Zydus Pharma recall products in US market
✔️ Dr Reddy's Lab launches generic stomach ulcer drug in US market
✔️ Dr Reddy's launches generic stomach ulcer drug in US market
✔️ Dr Reddy's profit rises 30% to Rs 992 crore, revenue rises by 18% to Rs 5,763 crore in Q2
✔️ Dr Reddys Labs gains 7% as profit grows 30% YoY in Q2, margins expand
✔️ Dr Reddy's Q2 profit rises 30% to 992 cr; stock up 6%
✔️ Dr Reddy's Q2 Results Preview: Revenue expected to increase 4-5%, PAT to decline 15%
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
-: Stock News :- DRREDDY 05-08-2021 To 19-05-2022
✔️ Mandaviya holds meeting with Dr Reddy's Chairman on Sputnik V supply
✔️ Dr Reddy's to sell US, Canada territory rights for migraine drug to BDSI
✔️ Dr Reddy's sells Elyxyb's rights in US, Canada to BDSI
✔️ Dr Reddy's launches generic stomach ulcer drug in US market
✔️ Dr Reddy's profit rises 30% to Rs 992 crore, revenue rises by 18% to Rs 5,763 crore in Q2
✔️ Dr Reddys Labs gains 7% as profit grows 30% YoY in Q2, margins expand
✔️ Dr Reddy's Q2 profit rises 30% to 992 cr; stock up 6%
✔️ Dr Reddy's Q2 Results Preview: Revenue expected to increase 4-5%, PAT to decline 15%
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
-: Stock News :- DRREDDY 03-08-2021 To 19-05-2022
✔️ Ceat, Dr Reddy's: Be careful! These 5 stocks can dip up to 15% from here
✔️ Dr Reddy's to sell US, Canada territory rights for migraine drug to BDSI
✔️ Dr Reddy's sells Elyxyb's rights in US, Canada to BDSI
✔️ Dr Reddy's launches generic stomach ulcer drug in US market
✔️ Dr Reddy's profit rises 30% to Rs 992 crore, revenue rises by 18% to Rs 5,763 crore in Q2
✔️ Dr Reddys Labs gains 7% as profit grows 30% YoY in Q2, margins expand
✔️ Dr Reddy's Q2 profit rises 30% to 992 cr; stock up 6%
✔️ Dr Reddy's Q2 Results Preview: Revenue expected to increase 4-5%, PAT to decline 15%
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
-: Stock News :- DRREDDY 02-08-2021 To 19-05-2022
✔️ Hold Dr Reddy's Laboratories: target of Rs 5250: ICICI Direct
✔️ Dr Reddy's to sell US, Canada territory rights for migraine drug to BDSI
✔️ Dr Reddy's sells Elyxyb's rights in US, Canada to BDSI
✔️ Dr Reddy's launches generic stomach ulcer drug in US market
✔️ Dr Reddy's profit rises 30% to Rs 992 crore, revenue rises by 18% to Rs 5,763 crore in Q2
✔️ Dr Reddys Labs gains 7% as profit grows 30% YoY in Q2, margins expand
✔️ Dr Reddy's Q2 profit rises 30% to 992 cr; stock up 6%
✔️ Dr Reddy's Q2 Results Preview: Revenue expected to increase 4-5%, PAT to decline 15%
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
-: Stock News :- DRREDDY 30-07-2021 To 19-05-2022
✔️ India's worst-performing stock in July may rebound if history is any guide
✔️ India's worst performing stock may rebound if history is any guide
✔️ Dr Reddy's sells Elyxyb's rights in US, Canada to BDSI
✔️ Dr Reddy's launches generic stomach ulcer drug in US market
✔️ Dr Reddy's profit rises 30% to Rs 992 crore, revenue rises by 18% to Rs 5,763 crore in Q2
✔️ Dr Reddys Labs gains 7% as profit grows 30% YoY in Q2, margins expand
✔️ Dr Reddy's Q2 profit rises 30% to 992 cr; stock up 6%
✔️ Dr Reddy's Q2 Results Preview: Revenue expected to increase 4-5%, PAT to decline 15%
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
-: Stock News :- DRREDDY 28-07-2021 To 19-05-2022
✔️ Explainer: Why Dr Reddy's stock is taking hit post Q1FY22 earnings?
✔️ Dr Reddy's shares continue to bleed. Is it a 'buy on dip' opportunity?
✔️ Dr Reddy's extends fall on disappointing Q1; stock down 14% in 2 days
✔️ A subpoena and a soft Q1 impact sentiment for Dr Reddy's shares
✔️ Dr Reddy's profit rises 30% to Rs 992 crore, revenue rises by 18% to Rs 5,763 crore in Q2
✔️ Dr Reddys Labs gains 7% as profit grows 30% YoY in Q2, margins expand
✔️ Dr Reddy's Q2 profit rises 30% to 992 cr; stock up 6%
✔️ Dr Reddy's Q2 Results Preview: Revenue expected to increase 4-5%, PAT to decline 15%
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
-: Stock News :- DRREDDY 27-07-2021 To 27-07-2021
✔️ Dr Reddy's Labs: Quarter marked by strong launches, pricing erosion, weak margins and investigations
✔️ Dr Reddy's Labs Q1 net flat at 571 cr
✔️ Dr Reddy's shares tumble over 10 per cent post earnings announcement
✔️ Made in India Sputnik V to be available during Sept-October: Dr Reddy's
✔️ Dr Reddy's says investigating bribery allegations against it, in Ukraine and other CIS countries
✔️ Dr Reddy's Laboratories Q1 net down 1 pc at 571 cr
✔️ Dr Reddy's Labs Sheds 11% After Profit Falls To Rs 570 Crore In June Quarter
✔️ Dr Reddy's slips 8% post June quarter results, hits over 3-month low
✔️ Dr Reddy's Laboratories share price falls 3% post June quarter result
✔️ Dr Reddy's Q1 results: Consolidated PAT falls YoY to Rs 571 cr, misses estimates; sales rise 11%
✔️ Dr Reddy's Laboratories Q1 profit falls 1.5% to Rs 570.8 crore, revenue increases 11.4%
-: Stock News :- DRREDDY 24-07-2021 To 27-07-2021
✔️ Indian pharma industry to touch $130 bn by 2030: Dr Reddy's chairman
✔️ PLI scheme, a boost to Atmanirbhar Bharat Abhiyan: Dr Reddy's Chairman
✔️ Dr Reddy's shares tumble over 10 per cent post earnings announcement
✔️ Made in India Sputnik V to be available during Sept-October: Dr Reddy's
✔️ Dr Reddy's says investigating bribery allegations against it, in Ukraine and other CIS countries
✔️ Dr Reddy's Laboratories Q1 net down 1 pc at 571 cr
✔️ Dr Reddy's Labs Sheds 11% After Profit Falls To Rs 570 Crore In June Quarter
✔️ Dr Reddy's slips 8% post June quarter results, hits over 3-month low
✔️ Dr Reddy's Laboratories share price falls 3% post June quarter result
✔️ Dr Reddy's Q1 results: Consolidated PAT falls YoY to Rs 571 cr, misses estimates; sales rise 11%
✔️ Dr Reddy's Laboratories Q1 profit falls 1.5% to Rs 570.8 crore, revenue increases 11.4%
-: Stock News :- DRREDDY 15-07-2021 To 27-07-2021
✔️ These pharma stocks are Centrum Broking's top picks in the sector
✔️ PLI scheme, a boost to Atmanirbhar Bharat Abhiyan: Dr Reddy's Chairman
✔️ Dr Reddy's shares tumble over 10 per cent post earnings announcement
✔️ Made in India Sputnik V to be available during Sept-October: Dr Reddy's
✔️ Dr Reddy's says investigating bribery allegations against it, in Ukraine and other CIS countries
✔️ Dr Reddy's Laboratories Q1 net down 1 pc at 571 cr
✔️ Dr Reddy's Labs Sheds 11% After Profit Falls To Rs 570 Crore In June Quarter
✔️ Dr Reddy's slips 8% post June quarter results, hits over 3-month low
✔️ Dr Reddy's Laboratories share price falls 3% post June quarter result
✔️ Dr Reddy's Q1 results: Consolidated PAT falls YoY to Rs 571 cr, misses estimates; sales rise 11%
✔️ Dr Reddy's Laboratories Q1 profit falls 1.5% to Rs 570.8 crore, revenue increases 11.4%
-: Stock News :- DRREDDY 13-07-2021 To 27-07-2021
✔️ Sputnik V soft launched in over 50 cities in India: Dr Reddy's
✔️ Dr Reddy's to strengthen commercial roll-out of Sputnik V
✔️ Sputnik V's soft commercial launch not put on hold': Dr Reddy's
✔️ Commercial rollout of Sputnik V vaccine is not put on hold, says Dr Reddy's
✔️ Sputnik V second dose shortage to delay India's full rollout: Dr Reddy's
✔️ Sputnik V second dose shortage to delay India's full rollout: Dr Reddy's
✔️ PLUSS to provide transport, storage solution to Dr Reddy's for Sputnik V vaccine
✔️ Dr Reddy's slips 8% post June quarter results, hits over 3-month low
✔️ Dr Reddy's Laboratories share price falls 3% post June quarter result
✔️ Dr Reddy's Q1 results: Consolidated PAT falls YoY to Rs 571 cr, misses estimates; sales rise 11%
✔️ Dr Reddy's Laboratories Q1 profit falls 1.5% to Rs 570.8 crore, revenue increases 11.4%
-: Stock News :- DRREDDY 08-07-2021 To 27-07-2021
✔️ How Erez Israeli revived Dr Reddy's by focusing on costs and non-US markets
✔️ Dr Reddy's to strengthen commercial roll-out of Sputnik V
✔️ Sputnik V's soft commercial launch not put on hold': Dr Reddy's
✔️ Commercial rollout of Sputnik V vaccine is not put on hold, says Dr Reddy's
✔️ Sputnik V second dose shortage to delay India's full rollout: Dr Reddy's
✔️ Sputnik V second dose shortage to delay India's full rollout: Dr Reddy's
✔️ PLUSS to provide transport, storage solution to Dr Reddy's for Sputnik V vaccine
✔️ Dr Reddy's slips 8% post June quarter results, hits over 3-month low
✔️ Dr Reddy's Laboratories share price falls 3% post June quarter result
✔️ Dr Reddy's Q1 results: Consolidated PAT falls YoY to Rs 571 cr, misses estimates; sales rise 11%
✔️ Dr Reddy's Laboratories Q1 profit falls 1.5% to Rs 570.8 crore, revenue increases 11.4%
-: Stock News :- DRREDDY 07-07-2021 To 27-07-2021
✔️ Why Dr Reddy's shares have left Sun Pharma far behind recently
✔️ Dr Reddy's to strengthen commercial roll-out of Sputnik V
✔️ Sputnik V's soft commercial launch not put on hold': Dr Reddy's
✔️ Commercial rollout of Sputnik V vaccine is not put on hold, says Dr Reddy's
✔️ Sputnik V second dose shortage to delay India's full rollout: Dr Reddy's
✔️ Sputnik V second dose shortage to delay India's full rollout: Dr Reddy's
✔️ PLUSS to provide transport, storage solution to Dr Reddy's for Sputnik V vaccine
✔️ Dr Reddy's slips 8% post June quarter results, hits over 3-month low
✔️ Dr Reddy's Laboratories share price falls 3% post June quarter result
✔️ Dr Reddy's Q1 results: Consolidated PAT falls YoY to Rs 571 cr, misses estimates; sales rise 11%
✔️ Dr Reddy's Laboratories Q1 profit falls 1.5% to Rs 570.8 crore, revenue increases 11.4%
-: Stock News :- DRREDDY 04-07-2021 To 27-07-2021
✔️ Dr Reddy's expects business growth to be 'volatile' in FY22
✔️ Dr Reddy's to strengthen commercial roll-out of Sputnik V
✔️ Sputnik V's soft commercial launch not put on hold': Dr Reddy's
✔️ Commercial rollout of Sputnik V vaccine is not put on hold, says Dr Reddy's
✔️ Sputnik V second dose shortage to delay India's full rollout: Dr Reddy's
✔️ Sputnik V second dose shortage to delay India's full rollout: Dr Reddy's
✔️ PLUSS to provide transport, storage solution to Dr Reddy's for Sputnik V vaccine
✔️ Dr Reddy's slips 8% post June quarter results, hits over 3-month low
✔️ Dr Reddy's Laboratories share price falls 3% post June quarter result
✔️ Dr Reddy's Q1 results: Consolidated PAT falls YoY to Rs 571 cr, misses estimates; sales rise 11%
✔️ Dr Reddy's Laboratories Q1 profit falls 1.5% to Rs 570.8 crore, revenue increases 11.4%
-: Stock News :- DRREDDY 01-07-2021 To 27-07-2021
✔️ Sputnik Light: Dr Reddy's allowed to submit data of Russian Phase-III trials
✔️ Sputnik Light: SEC asks Dr Reddy's to submit data of phase-III trials
✔️ Sputnik Light: DCGI denies permission to Dr Reddy's for phase 3 trials
✔️ Govt panel denies permission to Dr Reddy's to conduct Sputnik Light phase-3 trials
✔️ India Coronavirus Dispatch: Zydus applies for nod to its 3-shot vaccine
✔️ Sputnik V second dose shortage to delay India's full rollout: Dr Reddy's
✔️ PLUSS to provide transport, storage solution to Dr Reddy's for Sputnik V vaccine
✔️ Dr Reddy's slips 8% post June quarter results, hits over 3-month low
✔️ Dr Reddy's Laboratories share price falls 3% post June quarter result
✔️ Dr Reddy's Q1 results: Consolidated PAT falls YoY to Rs 571 cr, misses estimates; sales rise 11%
✔️ Dr Reddy's Laboratories Q1 profit falls 1.5% to Rs 570.8 crore, revenue increases 11.4%
-: Stock News :- DRREDDY 29-06-2021 To 27-07-2021
✔️ Dr Reddy's is making the most of opportunities in vaccines, generics
✔️ Dr. Reddy's, cold chain solutions provider B Medical Systems tie-up for Sputnik rollout
✔️ B Medical Systems joins hands with Dr Reddy's for pan-India rollout of Sputnik V vaccines
✔️ Dr Reddy's says 'slight' delay in commercial rollout of Sputnik V vaccine
✔️ India Coronavirus Dispatch: Zydus applies for nod to its 3-shot vaccine
✔️ Sputnik V second dose shortage to delay India's full rollout: Dr Reddy's
✔️ PLUSS to provide transport, storage solution to Dr Reddy's for Sputnik V vaccine
✔️ Dr Reddy's slips 8% post June quarter results, hits over 3-month low
✔️ Dr Reddy's Laboratories share price falls 3% post June quarter result
✔️ Dr Reddy's Q1 results: Consolidated PAT falls YoY to Rs 571 cr, misses estimates; sales rise 11%
✔️ Dr Reddy's Laboratories Q1 profit falls 1.5% to Rs 570.8 crore, revenue increases 11.4%
-: Stock News :- DRREDDY 28-06-2021 To 27-07-2021
✔️ Dr Reddy's Laboratories announces commercial launch of Covid-19 drug 2-DG
✔️ Dr Reddy's Labs share price gains over launch of COVID-19 treatment drug
✔️ Sputnik V COVID-19 vaccine's rollout in Delhi-NCR delayed again
✔️ Dr Reddy's says 'slight' delay in commercial rollout of Sputnik V vaccine
✔️ India Coronavirus Dispatch: Zydus applies for nod to its 3-shot vaccine
✔️ Sputnik V second dose shortage to delay India's full rollout: Dr Reddy's
✔️ PLUSS to provide transport, storage solution to Dr Reddy's for Sputnik V vaccine
✔️ Dr Reddy's slips 8% post June quarter results, hits over 3-month low
✔️ Dr Reddy's Laboratories share price falls 3% post June quarter result
✔️ Dr Reddy's Q1 results: Consolidated PAT falls YoY to Rs 571 cr, misses estimates; sales rise 11%
✔️ Dr Reddy's Laboratories Q1 profit falls 1.5% to Rs 570.8 crore, revenue increases 11.4%
-: Stock News :- DRREDDY 22-06-2021 To 27-07-2021
✔️ Dr Reddy's launches Icosapent Ethyl capsules in US
✔️ Dr Reddy's launches generic version of triglyceride lowering drug Vascepa in US
✔️ Sputnik V COVID-19 vaccine's rollout in Delhi-NCR delayed again
✔️ Dr Reddy's says 'slight' delay in commercial rollout of Sputnik V vaccine
✔️ India Coronavirus Dispatch: Zydus applies for nod to its 3-shot vaccine
✔️ Sputnik V second dose shortage to delay India's full rollout: Dr Reddy's
✔️ PLUSS to provide transport, storage solution to Dr Reddy's for Sputnik V vaccine
✔️ Dr Reddy's slips 8% post June quarter results, hits over 3-month low
✔️ Dr Reddy's Laboratories share price falls 3% post June quarter result
✔️ Dr Reddy's Q1 results: Consolidated PAT falls YoY to Rs 571 cr, misses estimates; sales rise 11%
✔️ Dr Reddy's Laboratories Q1 profit falls 1.5% to Rs 570.8 crore, revenue increases 11.4%
-: Stock News :- DRREDDY 18-06-2021 To 27-07-2021
✔️ Sputnik V: Aster DM Healthcare partners with Dr Reddy's to administer vaccine in select locations
✔️ Dr Reddy's launches generic version of triglyceride lowering drug Vascepa in US
✔️ Sputnik V COVID-19 vaccine's rollout in Delhi-NCR delayed again
✔️ Dr Reddy's says 'slight' delay in commercial rollout of Sputnik V vaccine
✔️ India Coronavirus Dispatch: Zydus applies for nod to its 3-shot vaccine
✔️ Sputnik V second dose shortage to delay India's full rollout: Dr Reddy's
✔️ PLUSS to provide transport, storage solution to Dr Reddy's for Sputnik V vaccine
✔️ Dr Reddy's slips 8% post June quarter results, hits over 3-month low
✔️ Dr Reddy's Laboratories share price falls 3% post June quarter result
✔️ Dr Reddy's Q1 results: Consolidated PAT falls YoY to Rs 571 cr, misses estimates; sales rise 11%
✔️ Dr Reddy's Laboratories Q1 profit falls 1.5% to Rs 570.8 crore, revenue increases 11.4%
-: Stock News :- DRREDDY 16-06-2021 To 27-07-2021
✔️ Dr Reddy's in last leg of pilot launch of SputnikV vaccine
✔️ In final leg of Sputnik V pilot rollout, will announce commercial launch soon, says Dr Reddy's
✔️ Arbitration award: Dr Reddy's asked to pay $46.25 mn to Hatchtech in US
✔️ CSIR-IICT, Bengaluru pharma firm join hands to make Covid drug 2-DG
✔️ India Coronavirus Dispatch: Zydus applies for nod to its 3-shot vaccine
✔️ Sputnik V second dose shortage to delay India's full rollout: Dr Reddy's
✔️ PLUSS to provide transport, storage solution to Dr Reddy's for Sputnik V vaccine
✔️ Dr Reddy's slips 8% post June quarter results, hits over 3-month low
✔️ Dr Reddy's Laboratories share price falls 3% post June quarter result
✔️ Dr Reddy's Q1 results: Consolidated PAT falls YoY to Rs 571 cr, misses estimates; sales rise 11%
✔️ Dr Reddy's Laboratories Q1 profit falls 1.5% to Rs 570.8 crore, revenue increases 11.4%
-: Stock News :- DRREDDY 09-06-2021 To 27-07-2021
✔️ Dr Reddy's partners for cold storage of Sputnik V vaccine as nationwide launch draws closer
✔️ Hyderabad's Rockwell collaborates with Dr Reddy's Lab for Sputnik V rollout
✔️ Rockwell, Dr Reddy's tie up for Sputnik V vaccine roll-out in India
✔️ CSIR-IICT, Bengaluru pharma firm join hands to make Covid drug 2-DG
✔️ India Coronavirus Dispatch: Zydus applies for nod to its 3-shot vaccine
✔️ Sputnik V second dose shortage to delay India's full rollout: Dr Reddy's
✔️ PLUSS to provide transport, storage solution to Dr Reddy's for Sputnik V vaccine
✔️ Dr Reddy's slips 8% post June quarter results, hits over 3-month low
✔️ Dr Reddy's Laboratories share price falls 3% post June quarter result
✔️ Dr Reddy's Q1 results: Consolidated PAT falls YoY to Rs 571 cr, misses estimates; sales rise 11%
✔️ Dr Reddy's Laboratories Q1 profit falls 1.5% to Rs 570.8 crore, revenue increases 11.4%
-: Stock News :- DRREDDY 06-06-2021 To 27-07-2021
✔️ Manipal Hospitals collaborates with Dr Reddy's to include Sputnik V in vaccine portfolio
✔️ Manipal Hospitals partners with Dr Reddy's to include Sputnik V in its vaccine portfolio
✔️ Dr Reddy's recalls 2,980 bottles of cholesterol-lowering drug in US
✔️ Dr Reddy's recalls 2,980 cholesterol lowering drug bottles in US
✔️ Dr Reddy's recalls 2,980 bottles of cholesterol lowering drug in US
✔️ Dr Reddy's recalls 2,980 bottles of cholesterol lowering drug in US
✔️ Manipal Hospitals collaborates with Dr Reddy's for Sputnik V vaccine
✔️ Manipal Hospitals collaborates with Dr Reddy's to include Sputnik V in vaccine portfolio
✔️ Dr Reddy's Laboratories share price falls 3% post June quarter result
✔️ Dr Reddy's Q1 results: Consolidated PAT falls YoY to Rs 571 cr, misses estimates; sales rise 11%
✔️ Dr Reddy's Laboratories Q1 profit falls 1.5% to Rs 570.8 crore, revenue increases 11.4%
-: Stock News :- DRREDDY 04-06-2021 To 27-07-2021
✔️ BMC rejects all nine vaccine bids, in talk with Dr Reddy's for Sputnik jab
✔️ Manipal Hospitals partners with Dr Reddy's to include Sputnik V in its vaccine portfolio
✔️ Dr Reddy's recalls 2,980 bottles of cholesterol-lowering drug in US
✔️ Dr Reddy's recalls 2,980 cholesterol lowering drug bottles in US
✔️ Dr Reddy's recalls 2,980 bottles of cholesterol lowering drug in US
✔️ Dr Reddy's recalls 2,980 bottles of cholesterol lowering drug in US
✔️ Manipal Hospitals collaborates with Dr Reddy's for Sputnik V vaccine
✔️ Manipal Hospitals collaborates with Dr Reddy's to include Sputnik V in vaccine portfolio
✔️ Dr Reddy's Laboratories share price falls 3% post June quarter result
✔️ Dr Reddy's Q1 results: Consolidated PAT falls YoY to Rs 571 cr, misses estimates; sales rise 11%
✔️ Dr Reddy's Laboratories Q1 profit falls 1.5% to Rs 570.8 crore, revenue increases 11.4%
-: Stock News :- DRREDDY 03-06-2021 To 27-07-2021
✔️ Snowman Logistics partners with Dr Reddy's for Sputnik vaccine across India
✔️ Sputnik V: Snowman Logistics in pact with Dr Reddy's Laboratories
✔️ Snowman Logistics share price zooms 15% on tie-up with Dr Reddy's for Sputnik V delivery
✔️ Snowman Logistics partners with Dr Reddy's for Sputnik Covid-19 vaccine in India
✔️ Dr Reddy's recalls 2,980 bottles of cholesterol lowering drug in US
✔️ Dr Reddy's recalls 2,980 bottles of cholesterol lowering drug in US
✔️ Manipal Hospitals collaborates with Dr Reddy's for Sputnik V vaccine
✔️ Manipal Hospitals collaborates with Dr Reddy's to include Sputnik V in vaccine portfolio
✔️ Dr Reddy's Laboratories share price falls 3% post June quarter result
✔️ Dr Reddy's Q1 results: Consolidated PAT falls YoY to Rs 571 cr, misses estimates; sales rise 11%
✔️ Dr Reddy's Laboratories Q1 profit falls 1.5% to Rs 570.8 crore, revenue increases 11.4%
-: Stock News :- DRREDDY 02-06-2021 To 27-07-2021
✔️ Dr Reddy's to Cipla experts recommend 'buy' on these pharma stocks
✔️ Sputnik V: Snowman Logistics in pact with Dr Reddy's Laboratories
✔️ Snowman Logistics share price zooms 15% on tie-up with Dr Reddy's for Sputnik V delivery
✔️ Snowman Logistics partners with Dr Reddy's for Sputnik Covid-19 vaccine in India
✔️ Dr Reddy's recalls 2,980 bottles of cholesterol lowering drug in US
✔️ Dr Reddy's recalls 2,980 bottles of cholesterol lowering drug in US
✔️ Manipal Hospitals collaborates with Dr Reddy's for Sputnik V vaccine
✔️ Manipal Hospitals collaborates with Dr Reddy's to include Sputnik V in vaccine portfolio
✔️ Dr Reddy's Laboratories share price falls 3% post June quarter result
✔️ Dr Reddy's Q1 results: Consolidated PAT falls YoY to Rs 571 cr, misses estimates; sales rise 11%
✔️ Dr Reddy's Laboratories Q1 profit falls 1.5% to Rs 570.8 crore, revenue increases 11.4%
-: Stock News :- DRREDDY 28-05-2021 To 27-07-2021
✔️ Not authorised any third party to distribute COVID-19 vaccine in India, say RDIF and Dr Reddy's
✔️ Sputnik V: Snowman Logistics in pact with Dr Reddy's Laboratories
✔️ Snowman Logistics share price zooms 15% on tie-up with Dr Reddy's for Sputnik V delivery
✔️ Snowman Logistics partners with Dr Reddy's for Sputnik Covid-19 vaccine in India
✔️ Dr Reddy's recalls 2,980 bottles of cholesterol lowering drug in US
✔️ Dr Reddy's recalls 2,980 bottles of cholesterol lowering drug in US
✔️ Manipal Hospitals collaborates with Dr Reddy's for Sputnik V vaccine
✔️ Manipal Hospitals collaborates with Dr Reddy's to include Sputnik V in vaccine portfolio
✔️ Dr Reddy's Laboratories share price falls 3% post June quarter result
✔️ Dr Reddy's Q1 results: Consolidated PAT falls YoY to Rs 571 cr, misses estimates; sales rise 11%
✔️ Dr Reddy's Laboratories Q1 profit falls 1.5% to Rs 570.8 crore, revenue increases 11.4%
-: Stock News :- DRREDDY 24-05-2021 To 27-07-2021
✔️ Dr Reddy's earmarks capex worth Rs 1,000 cr for 2021-22 on growth outlook
✔️ Dr Reddy's lines up Rs 1,000 cr capex for current fiscal on growth outlook
✔️ Dr Reddy's lines up Rs 1,000 crore capex for current fiscal
✔️ Snowman Logistics partners with Dr Reddy's for Sputnik Covid-19 vaccine in India
✔️ Dr Reddy's recalls 2,980 bottles of cholesterol lowering drug in US
✔️ Dr Reddy's recalls 2,980 bottles of cholesterol lowering drug in US
✔️ Manipal Hospitals collaborates with Dr Reddy's for Sputnik V vaccine
✔️ Manipal Hospitals collaborates with Dr Reddy's to include Sputnik V in vaccine portfolio
✔️ Dr Reddy's Laboratories share price falls 3% post June quarter result
✔️ Dr Reddy's Q1 results: Consolidated PAT falls YoY to Rs 571 cr, misses estimates; sales rise 11%
✔️ Dr Reddy's Laboratories Q1 profit falls 1.5% to Rs 570.8 crore, revenue increases 11.4%
-: Stock News :- DRREDDY 23-05-2021 To 27-07-2021
✔️ Dr Reddy's developing new treatment options for Covid-19, says MD
✔️ Dr Reddy's lines up Rs 1,000 cr capex for current fiscal on growth outlook
✔️ Dr Reddy's lines up Rs 1,000 crore capex for current fiscal
✔️ Snowman Logistics partners with Dr Reddy's for Sputnik Covid-19 vaccine in India
✔️ Dr Reddy's recalls 2,980 bottles of cholesterol lowering drug in US
✔️ Dr Reddy's recalls 2,980 bottles of cholesterol lowering drug in US
✔️ Manipal Hospitals collaborates with Dr Reddy's for Sputnik V vaccine
✔️ Manipal Hospitals collaborates with Dr Reddy's to include Sputnik V in vaccine portfolio
✔️ Dr Reddy's Laboratories share price falls 3% post June quarter result
✔️ Dr Reddy's Q1 results: Consolidated PAT falls YoY to Rs 571 cr, misses estimates; sales rise 11%
✔️ Dr Reddy's Laboratories Q1 profit falls 1.5% to Rs 570.8 crore, revenue increases 11.4%
-: Stock News :- DRREDDY 20-05-2021 To 27-07-2021
✔️ Covid drug 2DG's price being fixed: Dr Reddy's
✔️ Dr Reddy's lines up Rs 1,000 cr capex for current fiscal on growth outlook
✔️ Dr Reddy's lines up Rs 1,000 crore capex for current fiscal
✔️ Snowman Logistics partners with Dr Reddy's for Sputnik Covid-19 vaccine in India
✔️ Dr Reddy's recalls 2,980 bottles of cholesterol lowering drug in US
✔️ Dr Reddy's recalls 2,980 bottles of cholesterol lowering drug in US
✔️ Manipal Hospitals collaborates with Dr Reddy's for Sputnik V vaccine
✔️ Manipal Hospitals collaborates with Dr Reddy's to include Sputnik V in vaccine portfolio
✔️ Dr Reddy's Laboratories share price falls 3% post June quarter result
✔️ Dr Reddy's Q1 results: Consolidated PAT falls YoY to Rs 571 cr, misses estimates; sales rise 11%
✔️ Dr Reddy's Laboratories Q1 profit falls 1.5% to Rs 570.8 crore, revenue increases 11.4%
-: Stock News :- DRREDDY 19-05-2021 To 27-07-2021
✔️ Dr Reddy's in talks with RDIF on Sputnik V for other countries
✔️ Dr Reddy's in talks with RDIF to sell Sputnik V in other countries
✔️ Dr Reddy's lines up Rs 1,000 crore capex for current fiscal
✔️ Snowman Logistics partners with Dr Reddy's for Sputnik Covid-19 vaccine in India
✔️ Dr Reddy's recalls 2,980 bottles of cholesterol lowering drug in US
✔️ Dr Reddy's recalls 2,980 bottles of cholesterol lowering drug in US
✔️ Manipal Hospitals collaborates with Dr Reddy's for Sputnik V vaccine
✔️ Manipal Hospitals collaborates with Dr Reddy's to include Sputnik V in vaccine portfolio
✔️ Dr Reddy's Laboratories share price falls 3% post June quarter result
✔️ Dr Reddy's Q1 results: Consolidated PAT falls YoY to Rs 571 cr, misses estimates; sales rise 11%
✔️ Dr Reddy's Laboratories Q1 profit falls 1.5% to Rs 570.8 crore, revenue increases 11.4%
-: Stock News :- DRREDDY 18-05-2021 To 27-07-2021
✔️ Dr. Reddy’s Laboratories is on the fast lane, after a slow start to FY21
✔️ Dr Reddy's in talks with RDIF to sell Sputnik V in other countries
✔️ Dr Reddy's lines up Rs 1,000 crore capex for current fiscal
✔️ Snowman Logistics partners with Dr Reddy's for Sputnik Covid-19 vaccine in India
✔️ Dr Reddy's recalls 2,980 bottles of cholesterol lowering drug in US
✔️ Dr Reddy's recalls 2,980 bottles of cholesterol lowering drug in US
✔️ Manipal Hospitals collaborates with Dr Reddy's for Sputnik V vaccine
✔️ Manipal Hospitals collaborates with Dr Reddy's to include Sputnik V in vaccine portfolio
✔️ Dr Reddy's Laboratories share price falls 3% post June quarter result
✔️ Dr Reddy's Q1 results: Consolidated PAT falls YoY to Rs 571 cr, misses estimates; sales rise 11%
✔️ Dr Reddy's Laboratories Q1 profit falls 1.5% to Rs 570.8 crore, revenue increases 11.4%
-: Stock News :- DRREDDY 17-05-2021 To 27-07-2021
✔️ Dr Reddy's: COVID opportunity gets wings
✔️ COVID-19: Dr Reddy's, Apollo Hospitals to start vaccination with Sputnik V
✔️ Shilpa Medicare inks deal with Dr Reddy's to manufacture Sputnik V vaccine
✔️ Dr Reddy's says 8-9 states have approached for Sputnik V vaccine procurement; announces tie-up with Apollo Hospitals
✔️ Apollo Hospitals begins pilot to administer SputnikV vaccines with Dr Reddy's Labs
✔️ Dr Reddy's Q4 a mixed bag; Covid portfolio, Sputnik to drive forward prospects
✔️ What should investors do with Dr Reddy's Labs post Q4 result: buy, sell or hold?
✔️ Manipal Hospitals collaborates with Dr Reddy's to include Sputnik V in vaccine portfolio
✔️ Dr Reddy's Laboratories share price falls 3% post June quarter result
✔️ Dr Reddy's Q1 results: Consolidated PAT falls YoY to Rs 571 cr, misses estimates; sales rise 11%
✔️ Dr Reddy's Laboratories Q1 profit falls 1.5% to Rs 570.8 crore, revenue increases 11.4%
-: Stock News :- DRREDDY 15-05-2021 To 27-07-2021
✔️ Dr Reddy's Lab Net Profit Declines 28% To Rs 553.5 Crore In March Quarter
✔️ COVID-19: Dr Reddy's, Apollo Hospitals to start vaccination with Sputnik V
✔️ Shilpa Medicare inks deal with Dr Reddy's to manufacture Sputnik V vaccine
✔️ Dr Reddy's says 8-9 states have approached for Sputnik V vaccine procurement; announces tie-up with Apollo Hospitals
✔️ Apollo Hospitals begins pilot to administer SputnikV vaccines with Dr Reddy's Labs
✔️ Dr Reddy's Q4 a mixed bag; Covid portfolio, Sputnik to drive forward prospects
✔️ What should investors do with Dr Reddy's Labs post Q4 result: buy, sell or hold?
✔️ Manipal Hospitals collaborates with Dr Reddy's to include Sputnik V in vaccine portfolio
✔️ Dr Reddy's Laboratories share price falls 3% post June quarter result
✔️ Dr Reddy's Q1 results: Consolidated PAT falls YoY to Rs 571 cr, misses estimates; sales rise 11%
✔️ Dr Reddy's Laboratories Q1 profit falls 1.5% to Rs 570.8 crore, revenue increases 11.4%
-: Stock News :- DRREDDY 14-05-2021 To 27-07-2021
✔️ COVID-19 | Dr Reddy's to launch 2-DG medication in June
✔️ COVID-19: Dr Reddy's, Apollo Hospitals to start vaccination with Sputnik V
✔️ Shilpa Medicare inks deal with Dr Reddy's to manufacture Sputnik V vaccine
✔️ Dr Reddy's says 8-9 states have approached for Sputnik V vaccine procurement; announces tie-up with Apollo Hospitals
✔️ Apollo Hospitals begins pilot to administer SputnikV vaccines with Dr Reddy's Labs
✔️ Dr Reddy's Q4 a mixed bag; Covid portfolio, Sputnik to drive forward prospects
✔️ What should investors do with Dr Reddy's Labs post Q4 result: buy, sell or hold?
✔️ Manipal Hospitals collaborates with Dr Reddy's to include Sputnik V in vaccine portfolio
✔️ Dr Reddy's Laboratories share price falls 3% post June quarter result
✔️ Dr Reddy's Q1 results: Consolidated PAT falls YoY to Rs 571 cr, misses estimates; sales rise 11%
✔️ Dr Reddy's Laboratories Q1 profit falls 1.5% to Rs 570.8 crore, revenue increases 11.4%
-: Stock News :- DRREDDY 30-06-2022 To 30-06-2022
✔️ JB Chemicals gets board approval to acquire Dr Reddy's 4 brands for 98 cr
✔️ Dr Reddy's settles patent litigation with Indivior, Aquestive Therapeutics
-: Stock News :- DRREDDY 24-06-2022 To 24-06-2022
✔️ Dr Reddy's settles therapeutic drug patent litigation with Indivior, Aquestive Therapeutics
✔️ Dr Reddy's acquire Eton Pharma's injectable products for $50 million
✔️ Dr Reddy's buys injectable product portfolio from Eton Pharmaceuticals for $50 m
✔️ Dr Reddy's Lab inks settlement pact with Indivior, Aquestive
✔️ Dr Reddy's to acquire injectable product portfolio from Eton Pharma for $50 mn
-: Stock News :- DRREDDY 22-06-2022 To 24-06-2022
✔️ 3 stocks to buy, accumulate with potential upside of up to 50%
✔️ Dr Reddy's acquire Eton Pharma's injectable products for $50 million
✔️ Dr Reddy's buys injectable product portfolio from Eton Pharmaceuticals for $50 m
✔️ Dr Reddy's Lab inks settlement pact with Indivior, Aquestive
✔️ Dr Reddy's to acquire injectable product portfolio from Eton Pharma for $50 mn
-: Stock News :- DRREDDY 16-06-2022 To 24-06-2022
✔️ LIC increases stake in Dr Reddy's
✔️ LIC ups stake in Dr Reddy's to 5.6 per cent
✔️ Dr Reddy's buys injectable product portfolio from Eton Pharmaceuticals for $50 m
✔️ Dr Reddy's Lab inks settlement pact with Indivior, Aquestive
✔️ Dr Reddy's to acquire injectable product portfolio from Eton Pharma for $50 mn
-: Stock News :- DRREDDY 14-06-2022 To 24-06-2022
✔️ Dr. Reddy's launches Nexavar generic in the US
✔️ LIC ups stake in Dr Reddy's to 5.6 per cent
✔️ Dr Reddy's buys injectable product portfolio from Eton Pharmaceuticals for $50 m
✔️ Dr Reddy's Lab inks settlement pact with Indivior, Aquestive
✔️ Dr Reddy's to acquire injectable product portfolio from Eton Pharma for $50 mn
-: Stock News :- DRREDDY 13-06-2022 To 24-06-2022
✔️ Top 10 trading ideas from experts for next 3-4 weeks as bears maul the markets
✔️ LIC ups stake in Dr Reddy's to 5.6 per cent
✔️ Dr Reddy's buys injectable product portfolio from Eton Pharmaceuticals for $50 m
✔️ Dr Reddy's Lab inks settlement pact with Indivior, Aquestive
✔️ Dr Reddy's to acquire injectable product portfolio from Eton Pharma for $50 mn
-: Stock News :- DRREDDY 10-06-2022 To 24-06-2022
✔️ Dr Reddy's arm inks pact with US-based Olema Pharmaceuticals
✔️ Dr Reddy's subsidiary inks pact with US-based Olema Pharmaceuticals
✔️ Dr Reddy's buys injectable product portfolio from Eton Pharmaceuticals for $50 m
✔️ Dr Reddy's Lab inks settlement pact with Indivior, Aquestive
✔️ Dr Reddy's to acquire injectable product portfolio from Eton Pharma for $50 mn
-: Stock News :- DRREDDY 07-06-2022 To 24-06-2022
✔️ Why the fall in Dr Reddy's stock today is unwarranted
✔️ Dr Reddy's subsidiary inks pact with US-based Olema Pharmaceuticals
✔️ Dr Reddy's buys injectable product portfolio from Eton Pharmaceuticals for $50 m
✔️ Dr Reddy's Lab inks settlement pact with Indivior, Aquestive
✔️ Dr Reddy's to acquire injectable product portfolio from Eton Pharma for $50 mn
-: Stock News :- DRREDDY 28-05-2022 To 24-06-2022
✔️ Dr Reddy's launches Pemetrexed injection in US
✔️ Dr Reddy's subsidiary inks pact with US-based Olema Pharmaceuticals
✔️ Dr Reddy's buys injectable product portfolio from Eton Pharmaceuticals for $50 m
✔️ Dr Reddy's Lab inks settlement pact with Indivior, Aquestive
✔️ Dr Reddy's to acquire injectable product portfolio from Eton Pharma for $50 mn
-: Stock News :- DRREDDY 25-05-2022 To 24-06-2022
✔️ Dr. Reddy's, Senores Pharmaceuticals launch Ketorolac Tromethamine tablets in US
✔️ Dr Reddy's subsidiary inks pact with US-based Olema Pharmaceuticals
✔️ Dr Reddy's buys injectable product portfolio from Eton Pharmaceuticals for $50 m
✔️ Dr Reddy's Lab inks settlement pact with Indivior, Aquestive
✔️ Dr Reddy's to acquire injectable product portfolio from Eton Pharma for $50 mn
-: Stock News :- DRREDDY 24-05-2022 To 24-06-2022
✔️ Buy Dr. Reddy's Laboratories; target of Rs 5261: KR Choksey
✔️ Dr Reddy's subsidiary inks pact with US-based Olema Pharmaceuticals
✔️ Dr Reddy's buys injectable product portfolio from Eton Pharmaceuticals for $50 m
✔️ Dr Reddy's Lab inks settlement pact with Indivior, Aquestive
✔️ Dr Reddy's to acquire injectable product portfolio from Eton Pharma for $50 mn
-: Stock News :- DRREDDY 22-05-2022 To 24-06-2022
✔️ Launches, base biz expansion tonic for Dr Reddy's double-digit growth
✔️ Dr Reddy's subsidiary inks pact with US-based Olema Pharmaceuticals
✔️ Dr Reddy's buys injectable product portfolio from Eton Pharmaceuticals for $50 m
✔️ Dr Reddy's Lab inks settlement pact with Indivior, Aquestive
✔️ Dr Reddy's to acquire injectable product portfolio from Eton Pharma for $50 mn
-: Stock News :- DRREDDY 21-05-2022 To 24-06-2022
✔️ Buy Dr Reddy's Laboratories; target of Rs 4800: ICICI Direct
✔️ Buy Dr. Reddy's Laboratories: target of Rs 5550: Sharekhan
✔️ Buy Dr Reddy's Labs; target of Rs 4800: Motilal Oswal
✔️ Dr Reddy's Lab inks settlement pact with Indivior, Aquestive
✔️ Dr Reddy's to acquire injectable product portfolio from Eton Pharma for $50 mn
-: Stock News :- DRREDDY 11-07-2022 To 11-07-2022
✔️ Dr Reddy's gains over 3% on new drug launch in the US market
-: Stock News :- DRREDDY 08-07-2022 To 08-07-2022
✔️ Dr Reddy's launches Fesoterodine Fumarate tablets in US
✔️ Dr Reddy's launches Fesoterodine Fumarate tablets in US
-: Stock News :- DRREDDY 07-07-2022 To 07-07-2022
✔️ Andhra plant gets two observations from USFDA: Dr Reddy's Laboratories
✔️ Dr Reddy's Lab says its Andhra plant gets two observations from USFDA
-: Stock News :- DRREDDY 06-07-2022 To 06-07-2022
✔️ Dr Reddy's says it aims to triple reach to 1.5 bn patients by 2030
✔️ Dr Reddy's aims to triple its reach to 1.5 billion patients by 2030
-: Stock News :- DRREDDY 01-07-2022 To 06-07-2022
✔️ JB Pharma acquires four brands from Dr Reddy's Laboratories for 98.3 crore
✔️ Dr Reddy's aims to triple its reach to 1.5 billion patients by 2030
-: Stock News :- DRREDDY 22-07-2022 To 22-07-2022
✔️ Dr Reddy's launches new product in US
✔️ Dr Reddy's launches new product in US
✔️ Dr Reddy's launches generic version of Allegra in US
-: Stock News :- DRREDDY 11-07-2022 To 22-07-2022
✔️ Dr Reddy's gains over 3% on new drug launch in the US market
✔️ Dr Reddy's launches new product in US
✔️ Dr Reddy's launches generic version of Allegra in US
-: Stock News :- DRREDDY 08-07-2022 To 22-07-2022
✔️ Dr Reddy's launches Fesoterodine Fumarate tablets in US
✔️ Dr Reddy's launches Fesoterodine Fumarate tablets in US
✔️ Dr Reddy's launches generic version of Allegra in US
-: Stock News :- DRREDDY 07-07-2022 To 22-07-2022
✔️ Andhra plant gets two observations from USFDA: Dr Reddy's Laboratories
✔️ Dr Reddy's Lab says its Andhra plant gets two observations from USFDA
✔️ Dr Reddy's launches generic version of Allegra in US
-: Stock News :- DRREDDY 06-07-2022 To 22-07-2022
✔️ Dr Reddy's says it aims to triple reach to 1.5 bn patients by 2030
✔️ Dr Reddy's aims to triple its reach to 1.5 billion patients by 2030
✔️ Dr Reddy's launches generic version of Allegra in US
-: Stock News :- DRREDDY 01-07-2022 To 22-07-2022
✔️ JB Pharma acquires four brands from Dr Reddy's Laboratories for 98.3 crore
✔️ Dr Reddy's aims to triple its reach to 1.5 billion patients by 2030
✔️ Dr Reddy's launches generic version of Allegra in US
-: Stock News :- DRREDDY 30-06-2022 To 22-07-2022
✔️ JB Chemicals gets board approval to acquire Dr Reddy's 4 brands for 98 cr
✔️ Dr Reddy's settles patent litigation with Indivior, Aquestive Therapeutics
✔️ Dr Reddy's launches generic version of Allegra in US
-: Stock News :- DRREDDY 30-07-2022 To 29-07-2022
✔️ Dr Reddy's Laboratories inks licensing pact with US' Slayback Pharma
✔️ Dr Reddy's inkslicensing pactwith Slayback Pharma for Lumify inUS
✔️ Dr Reddy's Q1: Even beyond one-offs, underlying results weak
-: Stock News :- DRREDDY 28-07-2022 To 28-07-2022
✔️ Dr Reddy's Q1 net at 1,188 crore, up 108% from Q1-FY21
✔️ Other income pushes Dr Reddy's PAT up 108 per cent at 1,188 Cr in Q1
✔️ Dr Reddy's PAT up 108% at Rs 1,188 crore in Q1
✔️ Dr Reddy's PAT soars 108% at Rs 1,188 crore in Q1; revenue rises 6%
-: Stock News :- DRREDDY 27-07-2022 To 28-07-2022
✔️ Dr Reddy's Q1 revenue may grow up to 10% YoY, margins may expand: Analysts
✔️ Dr Reddy's launches genericBortezomib injection in US
✔️ Dr Reddy's PAT up 108% at Rs 1,188 crore in Q1
✔️ Dr Reddy's PAT soars 108% at Rs 1,188 crore in Q1; revenue rises 6%
-: Stock News :- DRREDDY 22-07-2022 To 28-07-2022
✔️ Dr Reddy's launches new product in US
✔️ Dr Reddy's launches new product in US
✔️ Dr Reddy's launches generic version of Allegra in US
✔️ Dr Reddy's PAT soars 108% at Rs 1,188 crore in Q1; revenue rises 6%
-: Stock News :- DRREDDY 11-07-2022 To 28-07-2022
✔️ Dr Reddy's gains over 3% on new drug launch in the US market
✔️ Dr Reddy's launches new product in US
✔️ Dr Reddy's launches generic version of Allegra in US
✔️ Dr Reddy's PAT soars 108% at Rs 1,188 crore in Q1; revenue rises 6%
-: Stock News :- DRREDDY 08-07-2022 To 28-07-2022
✔️ Dr Reddy's launches Fesoterodine Fumarate tablets in US
✔️ Dr Reddy's launches Fesoterodine Fumarate tablets in US
✔️ Dr Reddy's launches generic version of Allegra in US
✔️ Dr Reddy's PAT soars 108% at Rs 1,188 crore in Q1; revenue rises 6%
-: Stock News :- DRREDDY 07-07-2022 To 28-07-2022
✔️ Andhra plant gets two observations from USFDA: Dr Reddy's Laboratories
✔️ Dr Reddy's Lab says its Andhra plant gets two observations from USFDA
✔️ Dr Reddy's launches generic version of Allegra in US
✔️ Dr Reddy's PAT soars 108% at Rs 1,188 crore in Q1; revenue rises 6%
-: Stock News :- DRREDDY 06-07-2022 To 28-07-2022
✔️ Dr Reddy's says it aims to triple reach to 1.5 bn patients by 2030
✔️ Dr Reddy's aims to triple its reach to 1.5 billion patients by 2030
✔️ Dr Reddy's launches generic version of Allegra in US
✔️ Dr Reddy's PAT soars 108% at Rs 1,188 crore in Q1; revenue rises 6%
-: Stock News :- DRREDDY 01-07-2022 To 28-07-2022
✔️ JB Pharma acquires four brands from Dr Reddy's Laboratories for 98.3 crore
✔️ Dr Reddy's aims to triple its reach to 1.5 billion patients by 2030
✔️ Dr Reddy's launches generic version of Allegra in US
✔️ Dr Reddy's PAT soars 108% at Rs 1,188 crore in Q1; revenue rises 6%
-: Stock News :- DRREDDY 30-06-2022 To 28-07-2022
✔️ JB Chemicals gets board approval to acquire Dr Reddy's 4 brands for 98 cr
✔️ Dr Reddy's settles patent litigation with Indivior, Aquestive Therapeutics
✔️ Dr Reddy's launches generic version of Allegra in US
✔️ Dr Reddy's PAT soars 108% at Rs 1,188 crore in Q1; revenue rises 6%
-: Stock News :- DRREDDY 02-08-2022 To 02-08-2022
✔️ Pharma, financial counters top on traders' chart
-: Stock News :- DRREDDY 15-08-2022 To 15-08-2022
✔️ Pharma@75: More innovation hubs need to come up in the country, says Satish Reddy
-: Stock News :- DRREDDY 19-08-2022 To 19-08-2022
✔️ Intercept Pharmaceuticals settles Ocaliva patent litigation case with Dr Reddy's
-: Stock News :- DRREDDY 17-08-2022 To 17-08-2022
✔️ At least 8 Indian companies working to develop monkeypox vaccine: Report
-: Stock News :- DRREDDY 30-08-2022 To 30-08-2022
✔️ Dr Reddy's, Aurigene ink MoU with DNDi on neglected tropical diseases
-: Stock News :- DRREDDY 26-08-2022 To 26-08-2022
✔️ Stocks to Watch Today | Dr Reddy's Laboratories, Syrma SGS Technology, Eicher Motors, and others in news today
-: Stock News :- DRREDDY 08-09-2022 To 08-09-2022
✔️ Dr. Reddy's launchesgeneric Revlimid capsules in the US
-: Stock News :- DRREDDY 11-10-2022 To 11-10-2022
✔️ WEF recognises Dr. Reddy's Hyderabad unit as part of GLN
✔️ WEF recognises Dr. Reddy's Hyd factory as part of its Global Lighthouse Network
-: Stock News :- DRREDDY 08-09-2022 To 11-10-2022
✔️ Dr. Reddy's launchesgeneric Revlimid capsules in the US
✔️ WEF recognises Dr. Reddy's Hyd factory as part of its Global Lighthouse Network
-: Stock News :- DRREDDY 30-08-2022 To 11-10-2022
✔️ Dr Reddy's, Aurigene ink MoU with DNDi on neglected tropical diseases
✔️ WEF recognises Dr. Reddy's Hyd factory as part of its Global Lighthouse Network
-: Stock News :- DRREDDY 26-08-2022 To 11-10-2022
✔️ Stocks to Watch Today | Dr Reddy's Laboratories, Syrma SGS Technology, Eicher Motors, and others in news today
✔️ WEF recognises Dr. Reddy's Hyd factory as part of its Global Lighthouse Network
-: Stock News :- DRREDDY 19-08-2022 To 11-10-2022
✔️ Intercept Pharmaceuticals settles Ocaliva patent litigation case with Dr Reddy's
✔️ WEF recognises Dr. Reddy's Hyd factory as part of its Global Lighthouse Network
-: Stock News :- DRREDDY 17-08-2022 To 11-10-2022
✔️ At least 8 Indian companies working to develop monkeypox vaccine: Report
✔️ WEF recognises Dr. Reddy's Hyd factory as part of its Global Lighthouse Network
-: Stock News :- DRREDDY 15-08-2022 To 11-10-2022
✔️ Pharma@75: More innovation hubs need to come up in the country, says Satish Reddy
✔️ WEF recognises Dr. Reddy's Hyd factory as part of its Global Lighthouse Network
-: Stock News :- DRREDDY 02-08-2022 To 11-10-2022
✔️ Pharma, financial counters top on traders' chart
✔️ WEF recognises Dr. Reddy's Hyd factory as part of its Global Lighthouse Network
-: Stock News :- DRREDDY 23-10-2022 To 23-10-2022
✔️ Dr Reddy's, Cipla, and Aurobindo units recall products in US market
-: Stock News :- DRREDDY 28-10-2022 To 28-10-2022
✔️ Dr Reddys Labs Standalone September 2022 Net Sales at Rs 4,880.30 crore, up 27.64% Y-o-Y
✔️ Dr Reddy's PAT rises 12% at Rs 1,113 cr in Q2
✔️ Dr Reddy's PAT up 12% at Rs 1,113 cr in Q2; revenue rises 9% to Rs 6,305 cr
✔️ Dr Reddy's Q2 profit rises 12% with new generic launches in US market
✔️ Dr Reddy's Q2 net up 12 per cent at Rs 1,113 cr
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
-: Stock News :- DRREDDY 27-10-2022 To 28-10-2022
✔️ Dr Reddy's Q2 preview: Pharma major likely to report sharp drop net profit on weak US biz
✔️ Dr Reddy's PAT rises 12% at Rs 1,113 cr in Q2
✔️ Dr Reddy's PAT up 12% at Rs 1,113 cr in Q2; revenue rises 9% to Rs 6,305 cr
✔️ Dr Reddy's Q2 profit rises 12% with new generic launches in US market
✔️ Dr Reddy's Q2 net up 12 per cent at Rs 1,113 cr
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
-: Stock News :- DRREDDY 23-10-2022 To 28-10-2022
✔️ Dr Reddy's, Cipla, and Aurobindo units recall products in US market
✔️ Dr Reddy's PAT rises 12% at Rs 1,113 cr in Q2
✔️ Dr Reddy's PAT up 12% at Rs 1,113 cr in Q2; revenue rises 9% to Rs 6,305 cr
✔️ Dr Reddy's Q2 profit rises 12% with new generic launches in US market
✔️ Dr Reddy's Q2 net up 12 per cent at Rs 1,113 cr
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
-: Stock News :- DRREDDY 11-10-2022 To 28-10-2022
✔️ WEF recognises Dr. Reddy's Hyderabad unit as part of GLN
✔️ WEF recognises Dr. Reddy's Hyd factory as part of its Global Lighthouse Network
✔️ Dr Reddy's PAT up 12% at Rs 1,113 cr in Q2; revenue rises 9% to Rs 6,305 cr
✔️ Dr Reddy's Q2 profit rises 12% with new generic launches in US market
✔️ Dr Reddy's Q2 net up 12 per cent at Rs 1,113 cr
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
-: Stock News :- DRREDDY 08-09-2022 To 28-10-2022
✔️ Dr. Reddy's launchesgeneric Revlimid capsules in the US
✔️ WEF recognises Dr. Reddy's Hyd factory as part of its Global Lighthouse Network
✔️ Dr Reddy's PAT up 12% at Rs 1,113 cr in Q2; revenue rises 9% to Rs 6,305 cr
✔️ Dr Reddy's Q2 profit rises 12% with new generic launches in US market
✔️ Dr Reddy's Q2 net up 12 per cent at Rs 1,113 cr
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
-: Stock News :- DRREDDY 30-08-2022 To 28-10-2022
✔️ Dr Reddy's, Aurigene ink MoU with DNDi on neglected tropical diseases
✔️ WEF recognises Dr. Reddy's Hyd factory as part of its Global Lighthouse Network
✔️ Dr Reddy's PAT up 12% at Rs 1,113 cr in Q2; revenue rises 9% to Rs 6,305 cr
✔️ Dr Reddy's Q2 profit rises 12% with new generic launches in US market
✔️ Dr Reddy's Q2 net up 12 per cent at Rs 1,113 cr
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
-: Stock News :- DRREDDY 26-08-2022 To 28-10-2022
✔️ Stocks to Watch Today | Dr Reddy's Laboratories, Syrma SGS Technology, Eicher Motors, and others in news today
✔️ WEF recognises Dr. Reddy's Hyd factory as part of its Global Lighthouse Network
✔️ Dr Reddy's PAT up 12% at Rs 1,113 cr in Q2; revenue rises 9% to Rs 6,305 cr
✔️ Dr Reddy's Q2 profit rises 12% with new generic launches in US market
✔️ Dr Reddy's Q2 net up 12 per cent at Rs 1,113 cr
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
-: Stock News :- DRREDDY 19-08-2022 To 28-10-2022
✔️ Intercept Pharmaceuticals settles Ocaliva patent litigation case with Dr Reddy's
✔️ WEF recognises Dr. Reddy's Hyd factory as part of its Global Lighthouse Network
✔️ Dr Reddy's PAT up 12% at Rs 1,113 cr in Q2; revenue rises 9% to Rs 6,305 cr
✔️ Dr Reddy's Q2 profit rises 12% with new generic launches in US market
✔️ Dr Reddy's Q2 net up 12 per cent at Rs 1,113 cr
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
-: Stock News :- DRREDDY 17-08-2022 To 28-10-2022
✔️ At least 8 Indian companies working to develop monkeypox vaccine: Report
✔️ WEF recognises Dr. Reddy's Hyd factory as part of its Global Lighthouse Network
✔️ Dr Reddy's PAT up 12% at Rs 1,113 cr in Q2; revenue rises 9% to Rs 6,305 cr
✔️ Dr Reddy's Q2 profit rises 12% with new generic launches in US market
✔️ Dr Reddy's Q2 net up 12 per cent at Rs 1,113 cr
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
-: Stock News :- DRREDDY 15-08-2022 To 28-10-2022
✔️ Pharma@75: More innovation hubs need to come up in the country, says Satish Reddy
✔️ WEF recognises Dr. Reddy's Hyd factory as part of its Global Lighthouse Network
✔️ Dr Reddy's PAT up 12% at Rs 1,113 cr in Q2; revenue rises 9% to Rs 6,305 cr
✔️ Dr Reddy's Q2 profit rises 12% with new generic launches in US market
✔️ Dr Reddy's Q2 net up 12 per cent at Rs 1,113 cr
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
-: Stock News :- DRREDDY 02-08-2022 To 28-10-2022
✔️ Pharma, financial counters top on traders' chart
✔️ WEF recognises Dr. Reddy's Hyd factory as part of its Global Lighthouse Network
✔️ Dr Reddy's PAT up 12% at Rs 1,113 cr in Q2; revenue rises 9% to Rs 6,305 cr
✔️ Dr Reddy's Q2 profit rises 12% with new generic launches in US market
✔️ Dr Reddy's Q2 net up 12 per cent at Rs 1,113 cr
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
-: Stock News :- DRREDDY 30-07-2022 To 28-10-2022
✔️ Dr Reddy's Laboratories inks licensing pact with US' Slayback Pharma
✔️ Dr Reddy's inkslicensing pactwith Slayback Pharma for Lumify inUS
✔️ Dr Reddy's Q1: Even beyond one-offs, underlying results weak
✔️ Dr Reddy's Q2 profit rises 12% with new generic launches in US market
✔️ Dr Reddy's Q2 net up 12 per cent at Rs 1,113 cr
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
-: Stock News :- DRREDDY 28-07-2022 To 28-10-2022
✔️ Dr Reddy's Q1 net at 1,188 crore, up 108% from Q1-FY21
✔️ Other income pushes Dr Reddy's PAT up 108 per cent at 1,188 Cr in Q1
✔️ Dr Reddy's PAT up 108% at Rs 1,188 crore in Q1
✔️ Dr Reddy's PAT soars 108% at Rs 1,188 crore in Q1; revenue rises 6%
✔️ Dr Reddy's Q2 net up 12 per cent at Rs 1,113 cr
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
-: Stock News :- DRREDDY 27-07-2022 To 28-10-2022
✔️ Dr Reddy's Q1 revenue may grow up to 10% YoY, margins may expand: Analysts
✔️ Dr Reddy's launches genericBortezomib injection in US
✔️ Dr Reddy's PAT up 108% at Rs 1,188 crore in Q1
✔️ Dr Reddy's PAT soars 108% at Rs 1,188 crore in Q1; revenue rises 6%
✔️ Dr Reddy's Q2 net up 12 per cent at Rs 1,113 cr
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
-: Stock News :- DRREDDY 22-07-2022 To 28-10-2022
✔️ Dr Reddy's launches new product in US
✔️ Dr Reddy's launches new product in US
✔️ Dr Reddy's launches generic version of Allegra in US
✔️ Dr Reddy's PAT soars 108% at Rs 1,188 crore in Q1; revenue rises 6%
✔️ Dr Reddy's Q2 net up 12 per cent at Rs 1,113 cr
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
-: Stock News :- DRREDDY 11-07-2022 To 28-10-2022
✔️ Dr Reddy's gains over 3% on new drug launch in the US market
✔️ Dr Reddy's launches new product in US
✔️ Dr Reddy's launches generic version of Allegra in US
✔️ Dr Reddy's PAT soars 108% at Rs 1,188 crore in Q1; revenue rises 6%
✔️ Dr Reddy's Q2 net up 12 per cent at Rs 1,113 cr
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
-: Stock News :- DRREDDY 08-07-2022 To 28-10-2022
✔️ Dr Reddy's launches Fesoterodine Fumarate tablets in US
✔️ Dr Reddy's launches Fesoterodine Fumarate tablets in US
✔️ Dr Reddy's launches generic version of Allegra in US
✔️ Dr Reddy's PAT soars 108% at Rs 1,188 crore in Q1; revenue rises 6%
✔️ Dr Reddy's Q2 net up 12 per cent at Rs 1,113 cr
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
-: Stock News :- DRREDDY 07-07-2022 To 28-10-2022
✔️ Andhra plant gets two observations from USFDA: Dr Reddy's Laboratories
✔️ Dr Reddy's Lab says its Andhra plant gets two observations from USFDA
✔️ Dr Reddy's launches generic version of Allegra in US
✔️ Dr Reddy's PAT soars 108% at Rs 1,188 crore in Q1; revenue rises 6%
✔️ Dr Reddy's Q2 net up 12 per cent at Rs 1,113 cr
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
-: Stock News :- DRREDDY 06-07-2022 To 28-10-2022
✔️ Dr Reddy's says it aims to triple reach to 1.5 bn patients by 2030
✔️ Dr Reddy's aims to triple its reach to 1.5 billion patients by 2030
✔️ Dr Reddy's launches generic version of Allegra in US
✔️ Dr Reddy's PAT soars 108% at Rs 1,188 crore in Q1; revenue rises 6%
✔️ Dr Reddy's Q2 net up 12 per cent at Rs 1,113 cr
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
-: Stock News :- DRREDDY 01-07-2022 To 28-10-2022
✔️ JB Pharma acquires four brands from Dr Reddy's Laboratories for 98.3 crore
✔️ Dr Reddy's aims to triple its reach to 1.5 billion patients by 2030
✔️ Dr Reddy's launches generic version of Allegra in US
✔️ Dr Reddy's PAT soars 108% at Rs 1,188 crore in Q1; revenue rises 6%
✔️ Dr Reddy's Q2 net up 12 per cent at Rs 1,113 cr
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
-: Stock News :- DRREDDY 30-06-2022 To 28-10-2022
✔️ JB Chemicals gets board approval to acquire Dr Reddy's 4 brands for 98 cr
✔️ Dr Reddy's settles patent litigation with Indivior, Aquestive Therapeutics
✔️ Dr Reddy's launches generic version of Allegra in US
✔️ Dr Reddy's PAT soars 108% at Rs 1,188 crore in Q1; revenue rises 6%
✔️ Dr Reddy's Q2 net up 12 per cent at Rs 1,113 cr
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
-: Stock News :- DRREDDY 24-06-2022 To 28-10-2022
✔️ Dr Reddy's settles therapeutic drug patent litigation with Indivior, Aquestive Therapeutics
✔️ Dr Reddy's acquire Eton Pharma's injectable products for $50 million
✔️ Dr Reddy's buys injectable product portfolio from Eton Pharmaceuticals for $50 m
✔️ Dr Reddy's Lab inks settlement pact with Indivior, Aquestive
✔️ Dr Reddy's to acquire injectable product portfolio from Eton Pharma for $50 mn
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
-: Stock News :- DRREDDY 22-06-2022 To 28-10-2022
✔️ 3 stocks to buy, accumulate with potential upside of up to 50%
✔️ Dr Reddy's acquire Eton Pharma's injectable products for $50 million
✔️ Dr Reddy's buys injectable product portfolio from Eton Pharmaceuticals for $50 m
✔️ Dr Reddy's Lab inks settlement pact with Indivior, Aquestive
✔️ Dr Reddy's to acquire injectable product portfolio from Eton Pharma for $50 mn
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
-: Stock News :- DRREDDY 16-06-2022 To 28-10-2022
✔️ LIC increases stake in Dr Reddy's
✔️ LIC ups stake in Dr Reddy's to 5.6 per cent
✔️ Dr Reddy's buys injectable product portfolio from Eton Pharmaceuticals for $50 m
✔️ Dr Reddy's Lab inks settlement pact with Indivior, Aquestive
✔️ Dr Reddy's to acquire injectable product portfolio from Eton Pharma for $50 mn
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
-: Stock News :- DRREDDY 14-06-2022 To 28-10-2022
✔️ Dr. Reddy's launches Nexavar generic in the US
✔️ LIC ups stake in Dr Reddy's to 5.6 per cent
✔️ Dr Reddy's buys injectable product portfolio from Eton Pharmaceuticals for $50 m
✔️ Dr Reddy's Lab inks settlement pact with Indivior, Aquestive
✔️ Dr Reddy's to acquire injectable product portfolio from Eton Pharma for $50 mn
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
-: Stock News :- DRREDDY 13-06-2022 To 28-10-2022
✔️ Top 10 trading ideas from experts for next 3-4 weeks as bears maul the markets
✔️ LIC ups stake in Dr Reddy's to 5.6 per cent
✔️ Dr Reddy's buys injectable product portfolio from Eton Pharmaceuticals for $50 m
✔️ Dr Reddy's Lab inks settlement pact with Indivior, Aquestive
✔️ Dr Reddy's to acquire injectable product portfolio from Eton Pharma for $50 mn
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
-: Stock News :- DRREDDY 10-06-2022 To 28-10-2022
✔️ Dr Reddy's arm inks pact with US-based Olema Pharmaceuticals
✔️ Dr Reddy's subsidiary inks pact with US-based Olema Pharmaceuticals
✔️ Dr Reddy's buys injectable product portfolio from Eton Pharmaceuticals for $50 m
✔️ Dr Reddy's Lab inks settlement pact with Indivior, Aquestive
✔️ Dr Reddy's to acquire injectable product portfolio from Eton Pharma for $50 mn
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
-: Stock News :- DRREDDY 07-06-2022 To 28-10-2022
✔️ Why the fall in Dr Reddy's stock today is unwarranted
✔️ Dr Reddy's subsidiary inks pact with US-based Olema Pharmaceuticals
✔️ Dr Reddy's buys injectable product portfolio from Eton Pharmaceuticals for $50 m
✔️ Dr Reddy's Lab inks settlement pact with Indivior, Aquestive
✔️ Dr Reddy's to acquire injectable product portfolio from Eton Pharma for $50 mn
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
-: Stock News :- DRREDDY 28-05-2022 To 28-10-2022
✔️ Dr Reddy's launches Pemetrexed injection in US
✔️ Dr Reddy's subsidiary inks pact with US-based Olema Pharmaceuticals
✔️ Dr Reddy's buys injectable product portfolio from Eton Pharmaceuticals for $50 m
✔️ Dr Reddy's Lab inks settlement pact with Indivior, Aquestive
✔️ Dr Reddy's to acquire injectable product portfolio from Eton Pharma for $50 mn
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
-: Stock News :- DRREDDY 25-05-2022 To 28-10-2022
✔️ Dr. Reddy's, Senores Pharmaceuticals launch Ketorolac Tromethamine tablets in US
✔️ Dr Reddy's subsidiary inks pact with US-based Olema Pharmaceuticals
✔️ Dr Reddy's buys injectable product portfolio from Eton Pharmaceuticals for $50 m
✔️ Dr Reddy's Lab inks settlement pact with Indivior, Aquestive
✔️ Dr Reddy's to acquire injectable product portfolio from Eton Pharma for $50 mn
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
-: Stock News :- DRREDDY 24-05-2022 To 28-10-2022
✔️ Buy Dr. Reddy's Laboratories; target of Rs 5261: KR Choksey
✔️ Dr Reddy's subsidiary inks pact with US-based Olema Pharmaceuticals
✔️ Dr Reddy's buys injectable product portfolio from Eton Pharmaceuticals for $50 m
✔️ Dr Reddy's Lab inks settlement pact with Indivior, Aquestive
✔️ Dr Reddy's to acquire injectable product portfolio from Eton Pharma for $50 mn
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
-: Stock News :- DRREDDY 22-05-2022 To 28-10-2022
✔️ Launches, base biz expansion tonic for Dr Reddy's double-digit growth
✔️ Dr Reddy's subsidiary inks pact with US-based Olema Pharmaceuticals
✔️ Dr Reddy's buys injectable product portfolio from Eton Pharmaceuticals for $50 m
✔️ Dr Reddy's Lab inks settlement pact with Indivior, Aquestive
✔️ Dr Reddy's to acquire injectable product portfolio from Eton Pharma for $50 mn
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
-: Stock News :- DRREDDY 21-05-2022 To 28-10-2022
✔️ Buy Dr Reddy's Laboratories; target of Rs 4800: ICICI Direct
✔️ Buy Dr. Reddy's Laboratories: target of Rs 5550: Sharekhan
✔️ Buy Dr Reddy's Labs; target of Rs 4800: Motilal Oswal
✔️ Dr Reddy's Lab inks settlement pact with Indivior, Aquestive
✔️ Dr Reddy's to acquire injectable product portfolio from Eton Pharma for $50 mn
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
-: Stock News :- DRREDDY 01-11-2022 To 31-10-2022
✔️ Buy Dr Reddy's Labs; target of Rs 5180: Motilal Oswal
✔️ Buy Dr Reddy's Laboratories; target of Rs 5215: ICICI Direct
✔️ Buy Dr. Reddy's Laboratories; target of Rs 4900: Prabhudas Lilladher
-: Stock News :- DRREDDY 31-10-2022 To 31-10-2022
✔️ Results Earnings Call for Q2FY23 of Dr. Reddy's Laboratories Ltd.
✔️ Dr Reddy's surges as Revlimid generic helps drug maker sprint past estimates
✔️ Dr Reddy's 2Q: Key takeaways for investors
-: Stock News :- DRREDDY 06-11-2022 To 06-11-2022
✔️ Dr Reddy's lines up Rs 1,500 cr capex, to focus on biosimilars, injectables
✔️ Dr Reddy's To Earmark Rs 1,500 Crore Capex For Biosimilars, Injectables
-: Stock News :- DRREDDY 25-11-2022 To 25-11-2022
✔️ About 25% of Dr Reddy's products to be first-to-market by 2027: Co-chairman GV Prasad
✔️ About 25% of Dr. Reddy's product launches to be first-to-market by 2027: Co-chairman GV Prasad
-: Stock News :- DRREDDY 22-11-2022 To 22-11-2022
✔️ Antitrust Litigation Filed Against Dr Reddy's Laboratories In US
✔️ Dr Reddy's faces anti-trustsuit in US court over Revlimid
-: Stock News :- DRREDDY 20-11-2022 To 22-11-2022
✔️ Dr Reddy's is now No.2 drug firm as old order changes
✔️ Dr Reddy's faces anti-trustsuit in US court over Revlimid
-: Stock News :- DRREDDY 04-12-2022 To 04-12-2022
✔️ Dr Reddy's, Sun Pharma recall products in US for manufacturing issues
✔️ Dr Reddy's, Sun Pharma recall products in US for manufacturing issues
-: Stock News :- DRREDDY 28-06-2022 To 28-10-2022
✔️ Investor Day Transcript: Dr. Reddy's Laboratories
✔️ Dr Reddy's settles patent litigation with Indivior, Aquestive Therapeutics
✔️ Dr Reddy's launches generic version of Allegra in US
✔️ Dr Reddy's PAT soars 108% at Rs 1,188 crore in Q1; revenue rises 6%
✔️ Dr Reddy's Q2 net up 12 per cent at Rs 1,113 cr
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
-: Stock News :- DRREDDY 19-05-2022 To 19-05-2022
✔️ Q4FY22 Quarterly Result Announced for Dr. Reddy's Laboratories Ltd.
✔️ As Dr Reddy's rises after earnings, should you buy or sell stock?
✔️ Dr Reddy'sQ4 net down 76% at 88 crore
✔️ Dr Reddy's Lab to approach regulator for Sputnik Light as booster dose
✔️ Dr Reddy's Labs Q4 PAT falls 76% on pricing pressure, low export benefit
✔️ Dr Reddy'sQ4 net profit down 76% at 88 crore
✔️ Impairment hit: Dr Reddy's net profit declines 76% to Rs 88 cr in Q4
✔️ Dr Reddy's Q4 PAT falls 76% YoY on impairment costs; misses estimates
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
-: Stock News :- DRREDDY 16-12-2022 To 16-12-2022
✔️ Dr Reddy's arm haltsdevelopment of oral drug forpsoriasis
-: Stock News :- DRREDDY 29-12-2022 To 29-12-2022
✔️ Revlimid: Claims against Dr Reddy's in US court dismissed
✔️ Claims against Dr Reddy's Laboratories over Revlimid in US dismissed
✔️ There's no going back on digitalisation: Satish Reddy of Dr Reddy's Laboratories
✔️ Claims against Dr Reddy's over Revlimid in US dismissed
✔️ Dr Reddy's shares gain after US dismisses claims against Revelimid
-: Stock News :- DRREDDY 27-12-2022 To 29-12-2022
✔️ Broker's call: Dr Reddy's Laboratories (Buy)
✔️ Claims against Dr Reddy's Laboratories over Revlimid in US dismissed
✔️ There's no going back on digitalisation: Satish Reddy of Dr Reddy's Laboratories
✔️ Claims against Dr Reddy's over Revlimid in US dismissed
✔️ Dr Reddy's shares gain after US dismisses claims against Revelimid
-: Stock News :- DRREDDY 23-12-2022 To 29-12-2022
✔️ Corbevax maximises protection in Covishield vaccinated people: Study
✔️ Claims against Dr Reddy's Laboratories over Revlimid in US dismissed
✔️ There's no going back on digitalisation: Satish Reddy of Dr Reddy's Laboratories
✔️ Claims against Dr Reddy's over Revlimid in US dismissed
✔️ Dr Reddy's shares gain after US dismisses claims against Revelimid
-: Stock News :- DRREDDY 22-12-2022 To 29-12-2022
✔️ Buy Dr. Reddy's Laboratories; target of Rs 5460: Sharekhan
✔️ Claims against Dr Reddy's Laboratories over Revlimid in US dismissed
✔️ There's no going back on digitalisation: Satish Reddy of Dr Reddy's Laboratories
✔️ Claims against Dr Reddy's over Revlimid in US dismissed
✔️ Dr Reddy's shares gain after US dismisses claims against Revelimid
-: Stock News :- DRREDDY 19-12-2022 To 29-12-2022
✔️ Pharma industry needs govt's research-push to scale innovation challenges: Satish Reddy
✔️ Dr Reddy's completes phase 1 study for biosimilar of tocilizumab
✔️ Dr Reddy's completes phase-1 trialsof arthritistocilizumab biosimilar
✔️ Claims against Dr Reddy's over Revlimid in US dismissed
✔️ Dr Reddy's shares gain after US dismisses claims against Revelimid
-: Stock News :- DRREDDY 16-12-2022 To 29-12-2022
✔️ Dr Reddy's arm haltsdevelopment of oral drug forpsoriasis
✔️ Dr Reddy's completes phase 1 study for biosimilar of tocilizumab
✔️ Dr Reddy's completes phase-1 trialsof arthritistocilizumab biosimilar
✔️ Claims against Dr Reddy's over Revlimid in US dismissed
✔️ Dr Reddy's shares gain after US dismisses claims against Revelimid
-: Stock News :- DRREDDY 04-12-2022 To 29-12-2022
✔️ Dr Reddy's, Sun Pharma recall products in US for manufacturing issues
✔️ Dr Reddy's, Sun Pharma recall products in US for manufacturing issues
✔️ Dr Reddy's completes phase-1 trialsof arthritistocilizumab biosimilar
✔️ Claims against Dr Reddy's over Revlimid in US dismissed
✔️ Dr Reddy's shares gain after US dismisses claims against Revelimid
-: Stock News :- DRREDDY 25-11-2022 To 29-12-2022
✔️ About 25% of Dr Reddy's products to be first-to-market by 2027: Co-chairman GV Prasad
✔️ About 25% of Dr. Reddy's product launches to be first-to-market by 2027: Co-chairman GV Prasad
✔️ Dr Reddy's completes phase-1 trialsof arthritistocilizumab biosimilar
✔️ Claims against Dr Reddy's over Revlimid in US dismissed
✔️ Dr Reddy's shares gain after US dismisses claims against Revelimid
-: Stock News :- DRREDDY 22-11-2022 To 29-12-2022
✔️ Antitrust Litigation Filed Against Dr Reddy's Laboratories In US
✔️ Dr Reddy's faces anti-trustsuit in US court over Revlimid
✔️ Dr Reddy's completes phase-1 trialsof arthritistocilizumab biosimilar
✔️ Claims against Dr Reddy's over Revlimid in US dismissed
✔️ Dr Reddy's shares gain after US dismisses claims against Revelimid
-: Stock News :- DRREDDY 20-11-2022 To 29-12-2022
✔️ Dr Reddy's is now No.2 drug firm as old order changes
✔️ Dr Reddy's faces anti-trustsuit in US court over Revlimid
✔️ Dr Reddy's completes phase-1 trialsof arthritistocilizumab biosimilar
✔️ Claims against Dr Reddy's over Revlimid in US dismissed
✔️ Dr Reddy's shares gain after US dismisses claims against Revelimid
-: Stock News :- DRREDDY 06-11-2022 To 29-12-2022
✔️ Dr Reddy's lines up Rs 1,500 cr capex, to focus on biosimilars, injectables
✔️ Dr Reddy's To Earmark Rs 1,500 Crore Capex For Biosimilars, Injectables
✔️ Dr Reddy's completes phase-1 trialsof arthritistocilizumab biosimilar
✔️ Claims against Dr Reddy's over Revlimid in US dismissed
✔️ Dr Reddy's shares gain after US dismisses claims against Revelimid
-: Stock News :- DRREDDY 01-11-2022 To 29-12-2022
✔️ Buy Dr Reddy's Labs; target of Rs 5180: Motilal Oswal
✔️ Buy Dr Reddy's Laboratories; target of Rs 5215: ICICI Direct
✔️ Buy Dr. Reddy's Laboratories; target of Rs 4900: Prabhudas Lilladher
✔️ Claims against Dr Reddy's over Revlimid in US dismissed
✔️ Dr Reddy's shares gain after US dismisses claims against Revelimid
-: Stock News :- DRREDDY 31-10-2022 To 29-12-2022
✔️ Results Earnings Call for Q2FY23 of Dr. Reddy's Laboratories Ltd.
✔️ Dr Reddy's surges as Revlimid generic helps drug maker sprint past estimates
✔️ Dr Reddy's 2Q: Key takeaways for investors
✔️ Claims against Dr Reddy's over Revlimid in US dismissed
✔️ Dr Reddy's shares gain after US dismisses claims against Revelimid
-: Stock News :- DRREDDY 13-01-2023 To 13-01-2023
✔️ Dr Reddy's acquires trademark rights for Pfizer breast cancer drug
✔️ Dr. Reddy's buys trademark rights for Primcyvfrom Pfizer for domestic market
-: Stock News :- DRREDDY 27-01-2023 To 27-01-2023
✔️ Buy Dr. Reddy's Laboratories, target of Rs 5460: Sharekhan
✔️ Broker's Call: Dr Reddy's (Buy)
✔️ Another great quarter for Dr Reddy's, but is it sustainable?
✔️ Dr Reddy's Q3 consolidated profit jumps 77%; what should investors do with the stock?
✔️ Dr Reddy's shares: Should you buy the pharma stock as Q3 net profit rises 77%?
-: Stock News :- DRREDDY 26-01-2023 To 27-01-2023
✔️ Dr. Reddy's Laboratories Results Earnings Call for Q3FY23
✔️ Broker's Call: Dr Reddy's (Buy)
✔️ Another great quarter for Dr Reddy's, but is it sustainable?
✔️ Dr Reddy's Q3 consolidated profit jumps 77%; what should investors do with the stock?
✔️ Dr Reddy's shares: Should you buy the pharma stock as Q3 net profit rises 77%?
-: Stock News :- DRREDDY 25-01-2023 To 25-01-2023
✔️ Q3FY23 Quarterly Result Announced for Dr. Reddy's Laboratories Ltd.
✔️ Dr Reddy's Q3 net profit surges 77% to 1,247 cr
✔️ Dr Reddy's reports 77% growth in Q3 consolidated profit
-: Stock News :- DRREDDY 24-01-2023 To 25-01-2023
✔️ Dr Reddy's Q3 Preview | Sharp drop in net profit likely on slump in US revenues
✔️ Dr Reddy's Q3 net profit surges 77% to 1,247 cr
✔️ Dr Reddy's reports 77% growth in Q3 consolidated profit
-: Stock News :- DRREDDY 20-01-2023 To 25-01-2023
✔️ Dr Reddy's completes clinical studies of rituximab biosimilar candidate
✔️ Dr Reddy's completes clinical studies of its proposed rituximab biosimilar candidate
✔️ Dr Reddy's reports 77% growth in Q3 consolidated profit
-: Stock News :- DRREDDY 18-01-2023 To 25-01-2023
✔️ Dr. Reddy's cuts price of cardiovascular drug, Cidmus
✔️ Dr Reddy's completes clinical studies of its proposed rituximab biosimilar candidate
✔️ Dr Reddy's reports 77% growth in Q3 consolidated profit
-: Stock News :- DRREDDY 13-01-2023 To 25-01-2023
✔️ Dr Reddy's acquires trademark rights for Pfizer breast cancer drug
✔️ Dr. Reddy's buys trademark rights for Primcyvfrom Pfizer for domestic market
✔️ Dr Reddy's reports 77% growth in Q3 consolidated profit
-: Stock News :- DRREDDY 29-01-2023 To 29-01-2023
✔️ Buy Dr. Reddy's Laboratories; target of Rs 4900: Prabhudas Lilladher
-: Stock News :- DRREDDY 25-01-2023 To 27-01-2023
✔️ Q3FY23 Quarterly Result Announced for Dr. Reddy's Laboratories Ltd.
✔️ Dr Reddy's Q3 net profit surges 77% to 1,247 cr
✔️ Dr Reddy's reports 77% growth in Q3 consolidated profit
✔️ Dr Reddy's Q3 consolidated profit jumps 77%; what should investors do with the stock?
✔️ Dr Reddy's shares: Should you buy the pharma stock as Q3 net profit rises 77%?
-: Stock News :- DRREDDY 24-01-2023 To 27-01-2023
✔️ Dr Reddy's Q3 Preview | Sharp drop in net profit likely on slump in US revenues
✔️ Dr Reddy's Q3 net profit surges 77% to 1,247 cr
✔️ Dr Reddy's reports 77% growth in Q3 consolidated profit
✔️ Dr Reddy's Q3 consolidated profit jumps 77%; what should investors do with the stock?
✔️ Dr Reddy's shares: Should you buy the pharma stock as Q3 net profit rises 77%?
-: Stock News :- DRREDDY 20-01-2023 To 27-01-2023
✔️ Dr Reddy's completes clinical studies of rituximab biosimilar candidate
✔️ Dr Reddy's completes clinical studies of its proposed rituximab biosimilar candidate
✔️ Dr Reddy's reports 77% growth in Q3 consolidated profit
✔️ Dr Reddy's Q3 consolidated profit jumps 77%; what should investors do with the stock?
✔️ Dr Reddy's shares: Should you buy the pharma stock as Q3 net profit rises 77%?
-: Stock News :- DRREDDY 18-01-2023 To 27-01-2023
✔️ Dr. Reddy's cuts price of cardiovascular drug, Cidmus
✔️ Dr Reddy's completes clinical studies of its proposed rituximab biosimilar candidate
✔️ Dr Reddy's reports 77% growth in Q3 consolidated profit
✔️ Dr Reddy's Q3 consolidated profit jumps 77%; what should investors do with the stock?
✔️ Dr Reddy's shares: Should you buy the pharma stock as Q3 net profit rises 77%?
-: Stock News :- DRREDDY 13-01-2023 To 27-01-2023
✔️ Dr Reddy's acquires trademark rights for Pfizer breast cancer drug
✔️ Dr. Reddy's buys trademark rights for Primcyvfrom Pfizer for domestic market
✔️ Dr Reddy's reports 77% growth in Q3 consolidated profit
✔️ Dr Reddy's Q3 consolidated profit jumps 77%; what should investors do with the stock?
✔️ Dr Reddy's shares: Should you buy the pharma stock as Q3 net profit rises 77%?
-: Stock News :- DRREDDY 17-02-2023 To 17-02-2023
✔️ Dr Reddy's Labs trades lower despite robust Q3 as Credit Suisse flags EBITDA worries
-: Stock News :- DRREDDY 09-02-2023 To 09-02-2023
✔️ Explore what tech can do for pharma industry: G V Prasad
-: Stock News :- DRREDDY 03-02-2023 To 03-02-2023
✔️ Dr Reddy's Chairman Satish Reddy bags ICT award
-: Stock News :- DRREDDY 13-03-2023 To 13-03-2023
✔️ LIC increases stake in Dr Reddy's Laboratories by 2%
-: Stock News :- DRREDDY 07-03-2023 To 07-03-2023
✔️ Dr Reddy's recalls over 4,000 bottles of drug in US due to packaging error
-: Stock News :- DRREDDY 28-02-2023 To 27-02-2023
✔️ Dr Reddy's improves growth prospects in US with Mayne deal
✔️ Dr Reddy's trades lower after buying US generics firm. What brokerages have to say
✔️ Dr Reddy's to buy Mayne Pharma's US generic portfolio for $105 million
✔️ Dr Reddy's acquires Mayne Pharma's USA prescription portfolio for $105 mn
✔️ Dr Reddy's to buy Mayne Pharma's US generic prescription product portfoliofor $105 million
-: Stock News :- DRREDDY 17-02-2023 To 27-02-2023
✔️ Dr Reddy's Labs trades lower despite robust Q3 as Credit Suisse flags EBITDA worries
✔️ Dr Reddy's trades lower after buying US generics firm. What brokerages have to say
✔️ Dr Reddy's to buy Mayne Pharma's US generic portfolio for $105 million
✔️ Dr Reddy's acquires Mayne Pharma's USA prescription portfolio for $105 mn
✔️ Dr Reddy's to buy Mayne Pharma's US generic prescription product portfoliofor $105 million
-: Stock News :- DRREDDY 09-02-2023 To 27-02-2023
✔️ Explore what tech can do for pharma industry: G V Prasad
✔️ Dr Reddy's trades lower after buying US generics firm. What brokerages have to say
✔️ Dr Reddy's to buy Mayne Pharma's US generic portfolio for $105 million
✔️ Dr Reddy's acquires Mayne Pharma's USA prescription portfolio for $105 mn
✔️ Dr Reddy's to buy Mayne Pharma's US generic prescription product portfoliofor $105 million
-: Stock News :- DRREDDY 03-02-2023 To 27-02-2023
✔️ Dr Reddy's Chairman Satish Reddy bags ICT award
✔️ Dr Reddy's trades lower after buying US generics firm. What brokerages have to say
✔️ Dr Reddy's to buy Mayne Pharma's US generic portfolio for $105 million
✔️ Dr Reddy's acquires Mayne Pharma's USA prescription portfolio for $105 mn
✔️ Dr Reddy's to buy Mayne Pharma's US generic prescription product portfoliofor $105 million
-: Stock News :- DRREDDY 29-01-2023 To 27-02-2023
✔️ Buy Dr. Reddy's Laboratories; target of Rs 4900: Prabhudas Lilladher
✔️ Dr Reddy's trades lower after buying US generics firm. What brokerages have to say
✔️ Dr Reddy's to buy Mayne Pharma's US generic portfolio for $105 million
✔️ Dr Reddy's acquires Mayne Pharma's USA prescription portfolio for $105 mn
✔️ Dr Reddy's to buy Mayne Pharma's US generic prescription product portfoliofor $105 million
-: Stock News :- DRREDDY 20-03-2023 To 20-03-2023
✔️ Coya Therapeutics licenses Dr. Reddy's Abatacept for COYA 302 development
-: Stock News :- DRREDDY 18-03-2023 To 18-03-2023
✔️ Movers & Shakers: Stocks that will see action this week
-: Stock News :- DRREDDY 17-03-2023 To 16-03-2023
✔️ Eris down 4% in 2 days post acquisition of 9 derma brands from Dr Reddy's
✔️ Dr Reddy's shares gain as drugmaker divests nine derma brands for Rs 275 cr
✔️ Eris buys nine dermatology brands from Dr. Reddy's for 275 cr
✔️ Eris Lifesciences Ltd buys 9 dermatology brands from Dr Reddy's for $33 mn
-: Stock News :- DRREDDY 13-03-2023 To 16-03-2023
✔️ LIC increases stake in Dr Reddy's Laboratories by 2%
✔️ Dr Reddy's shares gain as drugmaker divests nine derma brands for Rs 275 cr
✔️ Eris buys nine dermatology brands from Dr. Reddy's for 275 cr
✔️ Eris Lifesciences Ltd buys 9 dermatology brands from Dr Reddy's for $33 mn
-: Stock News :- DRREDDY 07-03-2023 To 16-03-2023
✔️ Dr Reddy's recalls over 4,000 bottles of drug in US due to packaging error
✔️ Dr Reddy's shares gain as drugmaker divests nine derma brands for Rs 275 cr
✔️ Eris buys nine dermatology brands from Dr. Reddy's for 275 cr
✔️ Eris Lifesciences Ltd buys 9 dermatology brands from Dr Reddy's for $33 mn
-: Stock News :- DRREDDY 21-04-2023 To 21-04-2023
✔️ Dr Reddy's launches generic Treprostinil injection
-: Stock News :- DRREDDY 18-04-2023 To 18-04-2023
✔️ Dr. Reddy's ropes in Sonu Sood as brand ambassador forRebalanz Vitors
-: Stock News :- DRREDDY 14-04-2023 To 14-04-2023
✔️ 3 sectors Mileen Vasudeo is bullish on for near term
-: Stock News :- DRREDDY 05-05-2023 To 05-05-2023
✔️ Dr Reddy's Laboratories launches Regadenoson injection in US market
✔️ Dr Reddy Share Price Live blog for 05 May 2023
-: Stock News :- DRREDDY 21-04-2023 To 05-05-2023
✔️ Dr Reddy's launches generic Treprostinil injection
✔️ Dr Reddy Share Price Live blog for 05 May 2023
-: Stock News :- DRREDDY 18-04-2023 To 05-05-2023
✔️ Dr. Reddy's ropes in Sonu Sood as brand ambassador forRebalanz Vitors
✔️ Dr Reddy Share Price Live blog for 05 May 2023
-: Stock News :- DRREDDY 14-04-2023 To 05-05-2023
✔️ 3 sectors Mileen Vasudeo is bullish on for near term
✔️ Dr Reddy Share Price Live blog for 05 May 2023
-: Stock News :- DRREDDY 20-03-2023 To 05-05-2023
✔️ Coya Therapeutics licenses Dr. Reddy's Abatacept for COYA 302 development
✔️ Dr Reddy Share Price Live blog for 05 May 2023
-: Stock News :- DRREDDY 18-03-2023 To 05-05-2023
✔️ Movers & Shakers: Stocks that will see action this week
✔️ Dr Reddy Share Price Live blog for 05 May 2023
-: Stock News :- DRREDDY 17-05-2023 To 17-05-2023
✔️ Pharma major Dr Reddy's says pipeline of complex drugs to drive revenue growth in next 4-5 years
✔️ Dr Reddy Share Price Live blog for 17 May 2023
-: Stock News :- DRREDDY 16-05-2023 To 17-05-2023
✔️ Dr Reddy Share Price Live blog for 16 May 2023
✔️ Pharma major Dr Reddy's says pipeline of complex drugs to drive revenue growth in next 4-5 years
✔️ Dr Reddy Share Price Live blog for 17 May 2023
-: Stock News :- DRREDDY 14-05-2023 To 17-05-2023
✔️ Buy Dr. Reddy's Laboratories; target of Rs 5155: KR Choksey
✔️ Pharma major Dr Reddy's says pipeline of complex drugs to drive revenue growth in next 4-5 years
✔️ Dr Reddy Share Price Live blog for 17 May 2023
-: Stock News :- DRREDDY 13-05-2023 To 10-05-2023
✔️ Reduce Dr. Reddy's Laboratories; target of Rs 4500: Prabhudas Lilladher
✔️ Neutral Dr Reddy's Labs; target of Rs 4500: Motilal Oswal
✔️ Dr Reddy Share Price Live blog for 12 May 2023
✔️ Dr Reddy's Q4 results: Why the stock fell 7% and what it means for investors
✔️ Dr Reddy's Laboratories QoQ showing catches a cold on weak US sales
✔️ Dr Reddy's Labs sinks 7% on disappointing Q4 operating performance
✔️ Dr Reddys Labs Consolidated March 2023 Net Sales at Rs 6,315.20 crore, up 15.35% Y-o-Y
-: Stock News :- DRREDDY 11-05-2023 To 10-05-2023
✔️ Q4FY23 Quarterly & FY23 Annual Result Announced for Dr. Reddy's Laboratories Ltd.
✔️ Dr Reddy's Q4FY23 results miss street's estimates; should you still own the stock?
✔️ Dr Reddy's fall 5% even after Q4 net profit jumps 10-fold. Here's why
✔️ Dr Reddy's shares falls over 5% on Thursday's trade following Q4FY23 results; check details
✔️ Dr Reddy Share Price Live blog for 11 May 2023
✔️ Stock Market Live: Positive open likely as US CPI eases; Dr Reddy, L&T eyed
✔️ Dr Reddys Labs Consolidated March 2023 Net Sales at Rs 6,315.20 crore, up 15.35% Y-o-Y
-: Stock News :- DRREDDY 10-05-2023 To 10-05-2023
✔️ Dr. Reddy's Laboratories Results Earnings Call for Q4FY23
✔️ Dr Reddy's Laboratories Q4 PAT grows nine-fold riding on US, India biz
✔️ L&T, Dr Reddy's Lab Q4 results: What should investors know before trading in share prices?
✔️ Dr Reddy's Q4 net profit soars to 959 crore
✔️ Dr Reddy's Q4: Firm declares dividend of 40, check details here
✔️ Dr Reddy's Labs Q4 result: PAT up 9 times, div declared at Rs 40 per share
✔️ Dr. Reddy's Q4FY23 results: Consolidated PAT at 959 cr, rises by 10-folds YoY; 800% dividend for shareholders
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 08-05-2023 To 10-05-2023
✔️ Dr Reddy's stock drops in trading today
✔️ Dr Reddy's Laboratories Q4 PAT grows nine-fold riding on US, India biz
✔️ L&T, Dr Reddy's Lab Q4 results: What should investors know before trading in share prices?
✔️ Dr Reddy's Q4 net profit soars to 959 crore
✔️ Dr Reddy's Q4: Firm declares dividend of 40, check details here
✔️ Dr Reddy's Labs Q4 result: PAT up 9 times, div declared at Rs 40 per share
✔️ Dr. Reddy's Q4FY23 results: Consolidated PAT at 959 cr, rises by 10-folds YoY; 800% dividend for shareholders
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 05-05-2023 To 10-05-2023
✔️ Dr Reddy's Laboratories launches Regadenoson injection in US market
✔️ Dr Reddy Share Price Live blog for 05 May 2023
✔️ L&T, Dr Reddy's Lab Q4 results: What should investors know before trading in share prices?
✔️ Dr Reddy's Q4 net profit soars to 959 crore
✔️ Dr Reddy's Q4: Firm declares dividend of 40, check details here
✔️ Dr Reddy's Labs Q4 result: PAT up 9 times, div declared at Rs 40 per share
✔️ Dr. Reddy's Q4FY23 results: Consolidated PAT at 959 cr, rises by 10-folds YoY; 800% dividend for shareholders
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 21-04-2023 To 10-05-2023
✔️ Dr Reddy's launches generic Treprostinil injection
✔️ Dr Reddy Share Price Live blog for 05 May 2023
✔️ L&T, Dr Reddy's Lab Q4 results: What should investors know before trading in share prices?
✔️ Dr Reddy's Q4 net profit soars to 959 crore
✔️ Dr Reddy's Q4: Firm declares dividend of 40, check details here
✔️ Dr Reddy's Labs Q4 result: PAT up 9 times, div declared at Rs 40 per share
✔️ Dr. Reddy's Q4FY23 results: Consolidated PAT at 959 cr, rises by 10-folds YoY; 800% dividend for shareholders
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 18-04-2023 To 10-05-2023
✔️ Dr. Reddy's ropes in Sonu Sood as brand ambassador forRebalanz Vitors
✔️ Dr Reddy Share Price Live blog for 05 May 2023
✔️ L&T, Dr Reddy's Lab Q4 results: What should investors know before trading in share prices?
✔️ Dr Reddy's Q4 net profit soars to 959 crore
✔️ Dr Reddy's Q4: Firm declares dividend of 40, check details here
✔️ Dr Reddy's Labs Q4 result: PAT up 9 times, div declared at Rs 40 per share
✔️ Dr. Reddy's Q4FY23 results: Consolidated PAT at 959 cr, rises by 10-folds YoY; 800% dividend for shareholders
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 14-04-2023 To 10-05-2023
✔️ 3 sectors Mileen Vasudeo is bullish on for near term
✔️ Dr Reddy Share Price Live blog for 05 May 2023
✔️ L&T, Dr Reddy's Lab Q4 results: What should investors know before trading in share prices?
✔️ Dr Reddy's Q4 net profit soars to 959 crore
✔️ Dr Reddy's Q4: Firm declares dividend of 40, check details here
✔️ Dr Reddy's Labs Q4 result: PAT up 9 times, div declared at Rs 40 per share
✔️ Dr. Reddy's Q4FY23 results: Consolidated PAT at 959 cr, rises by 10-folds YoY; 800% dividend for shareholders
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 20-03-2023 To 10-05-2023
✔️ Coya Therapeutics licenses Dr. Reddy's Abatacept for COYA 302 development
✔️ Dr Reddy Share Price Live blog for 05 May 2023
✔️ L&T, Dr Reddy's Lab Q4 results: What should investors know before trading in share prices?
✔️ Dr Reddy's Q4 net profit soars to 959 crore
✔️ Dr Reddy's Q4: Firm declares dividend of 40, check details here
✔️ Dr Reddy's Labs Q4 result: PAT up 9 times, div declared at Rs 40 per share
✔️ Dr. Reddy's Q4FY23 results: Consolidated PAT at 959 cr, rises by 10-folds YoY; 800% dividend for shareholders
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 18-03-2023 To 10-05-2023
✔️ Movers & Shakers: Stocks that will see action this week
✔️ Dr Reddy Share Price Live blog for 05 May 2023
✔️ L&T, Dr Reddy's Lab Q4 results: What should investors know before trading in share prices?
✔️ Dr Reddy's Q4 net profit soars to 959 crore
✔️ Dr Reddy's Q4: Firm declares dividend of 40, check details here
✔️ Dr Reddy's Labs Q4 result: PAT up 9 times, div declared at Rs 40 per share
✔️ Dr. Reddy's Q4FY23 results: Consolidated PAT at 959 cr, rises by 10-folds YoY; 800% dividend for shareholders
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 17-03-2023 To 10-05-2023
✔️ Eris down 4% in 2 days post acquisition of 9 derma brands from Dr Reddy's
✔️ Dr Reddy's shares gain as drugmaker divests nine derma brands for Rs 275 cr
✔️ Eris buys nine dermatology brands from Dr. Reddy's for 275 cr
✔️ Eris Lifesciences Ltd buys 9 dermatology brands from Dr Reddy's for $33 mn
✔️ Dr Reddy's Q4: Firm declares dividend of 40, check details here
✔️ Dr Reddy's Labs Q4 result: PAT up 9 times, div declared at Rs 40 per share
✔️ Dr. Reddy's Q4FY23 results: Consolidated PAT at 959 cr, rises by 10-folds YoY; 800% dividend for shareholders
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 13-03-2023 To 10-05-2023
✔️ LIC increases stake in Dr Reddy's Laboratories by 2%
✔️ Dr Reddy's shares gain as drugmaker divests nine derma brands for Rs 275 cr
✔️ Eris buys nine dermatology brands from Dr. Reddy's for 275 cr
✔️ Eris Lifesciences Ltd buys 9 dermatology brands from Dr Reddy's for $33 mn
✔️ Dr Reddy's Q4: Firm declares dividend of 40, check details here
✔️ Dr Reddy's Labs Q4 result: PAT up 9 times, div declared at Rs 40 per share
✔️ Dr. Reddy's Q4FY23 results: Consolidated PAT at 959 cr, rises by 10-folds YoY; 800% dividend for shareholders
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 07-03-2023 To 10-05-2023
✔️ Dr Reddy's recalls over 4,000 bottles of drug in US due to packaging error
✔️ Dr Reddy's shares gain as drugmaker divests nine derma brands for Rs 275 cr
✔️ Eris buys nine dermatology brands from Dr. Reddy's for 275 cr
✔️ Eris Lifesciences Ltd buys 9 dermatology brands from Dr Reddy's for $33 mn
✔️ Dr Reddy's Q4: Firm declares dividend of 40, check details here
✔️ Dr Reddy's Labs Q4 result: PAT up 9 times, div declared at Rs 40 per share
✔️ Dr. Reddy's Q4FY23 results: Consolidated PAT at 959 cr, rises by 10-folds YoY; 800% dividend for shareholders
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 28-02-2023 To 10-05-2023
✔️ Dr Reddy's improves growth prospects in US with Mayne deal
✔️ Dr Reddy's trades lower after buying US generics firm. What brokerages have to say
✔️ Dr Reddy's to buy Mayne Pharma's US generic portfolio for $105 million
✔️ Dr Reddy's acquires Mayne Pharma's USA prescription portfolio for $105 mn
✔️ Dr Reddy's to buy Mayne Pharma's US generic prescription product portfoliofor $105 million
✔️ Dr Reddy's Labs Q4 result: PAT up 9 times, div declared at Rs 40 per share
✔️ Dr. Reddy's Q4FY23 results: Consolidated PAT at 959 cr, rises by 10-folds YoY; 800% dividend for shareholders
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 17-02-2023 To 10-05-2023
✔️ Dr Reddy's Labs trades lower despite robust Q3 as Credit Suisse flags EBITDA worries
✔️ Dr Reddy's trades lower after buying US generics firm. What brokerages have to say
✔️ Dr Reddy's to buy Mayne Pharma's US generic portfolio for $105 million
✔️ Dr Reddy's acquires Mayne Pharma's USA prescription portfolio for $105 mn
✔️ Dr Reddy's to buy Mayne Pharma's US generic prescription product portfoliofor $105 million
✔️ Dr Reddy's Labs Q4 result: PAT up 9 times, div declared at Rs 40 per share
✔️ Dr. Reddy's Q4FY23 results: Consolidated PAT at 959 cr, rises by 10-folds YoY; 800% dividend for shareholders
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 09-02-2023 To 10-05-2023
✔️ Explore what tech can do for pharma industry: G V Prasad
✔️ Dr Reddy's trades lower after buying US generics firm. What brokerages have to say
✔️ Dr Reddy's to buy Mayne Pharma's US generic portfolio for $105 million
✔️ Dr Reddy's acquires Mayne Pharma's USA prescription portfolio for $105 mn
✔️ Dr Reddy's to buy Mayne Pharma's US generic prescription product portfoliofor $105 million
✔️ Dr Reddy's Labs Q4 result: PAT up 9 times, div declared at Rs 40 per share
✔️ Dr. Reddy's Q4FY23 results: Consolidated PAT at 959 cr, rises by 10-folds YoY; 800% dividend for shareholders
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 03-02-2023 To 10-05-2023
✔️ Dr Reddy's Chairman Satish Reddy bags ICT award
✔️ Dr Reddy's trades lower after buying US generics firm. What brokerages have to say
✔️ Dr Reddy's to buy Mayne Pharma's US generic portfolio for $105 million
✔️ Dr Reddy's acquires Mayne Pharma's USA prescription portfolio for $105 mn
✔️ Dr Reddy's to buy Mayne Pharma's US generic prescription product portfoliofor $105 million
✔️ Dr Reddy's Labs Q4 result: PAT up 9 times, div declared at Rs 40 per share
✔️ Dr. Reddy's Q4FY23 results: Consolidated PAT at 959 cr, rises by 10-folds YoY; 800% dividend for shareholders
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 29-01-2023 To 10-05-2023
✔️ Buy Dr. Reddy's Laboratories; target of Rs 4900: Prabhudas Lilladher
✔️ Dr Reddy's trades lower after buying US generics firm. What brokerages have to say
✔️ Dr Reddy's to buy Mayne Pharma's US generic portfolio for $105 million
✔️ Dr Reddy's acquires Mayne Pharma's USA prescription portfolio for $105 mn
✔️ Dr Reddy's to buy Mayne Pharma's US generic prescription product portfoliofor $105 million
✔️ Dr Reddy's Labs Q4 result: PAT up 9 times, div declared at Rs 40 per share
✔️ Dr. Reddy's Q4FY23 results: Consolidated PAT at 959 cr, rises by 10-folds YoY; 800% dividend for shareholders
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 27-01-2023 To 10-05-2023
✔️ Buy Dr. Reddy's Laboratories, target of Rs 5460: Sharekhan
✔️ Broker's Call: Dr Reddy's (Buy)
✔️ Another great quarter for Dr Reddy's, but is it sustainable?
✔️ Dr Reddy's Q3 consolidated profit jumps 77%; what should investors do with the stock?
✔️ Dr Reddy's shares: Should you buy the pharma stock as Q3 net profit rises 77%?
✔️ Dr Reddy's Labs Q4 result: PAT up 9 times, div declared at Rs 40 per share
✔️ Dr. Reddy's Q4FY23 results: Consolidated PAT at 959 cr, rises by 10-folds YoY; 800% dividend for shareholders
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 26-01-2023 To 10-05-2023
✔️ Dr. Reddy's Laboratories Results Earnings Call for Q3FY23
✔️ Broker's Call: Dr Reddy's (Buy)
✔️ Another great quarter for Dr Reddy's, but is it sustainable?
✔️ Dr Reddy's Q3 consolidated profit jumps 77%; what should investors do with the stock?
✔️ Dr Reddy's shares: Should you buy the pharma stock as Q3 net profit rises 77%?
✔️ Dr Reddy's Labs Q4 result: PAT up 9 times, div declared at Rs 40 per share
✔️ Dr. Reddy's Q4FY23 results: Consolidated PAT at 959 cr, rises by 10-folds YoY; 800% dividend for shareholders
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 25-01-2023 To 10-05-2023
✔️ Q3FY23 Quarterly Result Announced for Dr. Reddy's Laboratories Ltd.
✔️ Dr Reddy's Q3 net profit surges 77% to 1,247 cr
✔️ Dr Reddy's reports 77% growth in Q3 consolidated profit
✔️ Dr Reddy's Q3 consolidated profit jumps 77%; what should investors do with the stock?
✔️ Dr Reddy's shares: Should you buy the pharma stock as Q3 net profit rises 77%?
✔️ Dr Reddy's Labs Q4 result: PAT up 9 times, div declared at Rs 40 per share
✔️ Dr. Reddy's Q4FY23 results: Consolidated PAT at 959 cr, rises by 10-folds YoY; 800% dividend for shareholders
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 24-01-2023 To 10-05-2023
✔️ Dr Reddy's Q3 Preview | Sharp drop in net profit likely on slump in US revenues
✔️ Dr Reddy's Q3 net profit surges 77% to 1,247 cr
✔️ Dr Reddy's reports 77% growth in Q3 consolidated profit
✔️ Dr Reddy's Q3 consolidated profit jumps 77%; what should investors do with the stock?
✔️ Dr Reddy's shares: Should you buy the pharma stock as Q3 net profit rises 77%?
✔️ Dr Reddy's Labs Q4 result: PAT up 9 times, div declared at Rs 40 per share
✔️ Dr. Reddy's Q4FY23 results: Consolidated PAT at 959 cr, rises by 10-folds YoY; 800% dividend for shareholders
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 20-01-2023 To 10-05-2023
✔️ Dr Reddy's completes clinical studies of rituximab biosimilar candidate
✔️ Dr Reddy's completes clinical studies of its proposed rituximab biosimilar candidate
✔️ Dr Reddy's reports 77% growth in Q3 consolidated profit
✔️ Dr Reddy's Q3 consolidated profit jumps 77%; what should investors do with the stock?
✔️ Dr Reddy's shares: Should you buy the pharma stock as Q3 net profit rises 77%?
✔️ Dr Reddy's Labs Q4 result: PAT up 9 times, div declared at Rs 40 per share
✔️ Dr. Reddy's Q4FY23 results: Consolidated PAT at 959 cr, rises by 10-folds YoY; 800% dividend for shareholders
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 18-01-2023 To 10-05-2023
✔️ Dr. Reddy's cuts price of cardiovascular drug, Cidmus
✔️ Dr Reddy's completes clinical studies of its proposed rituximab biosimilar candidate
✔️ Dr Reddy's reports 77% growth in Q3 consolidated profit
✔️ Dr Reddy's Q3 consolidated profit jumps 77%; what should investors do with the stock?
✔️ Dr Reddy's shares: Should you buy the pharma stock as Q3 net profit rises 77%?
✔️ Dr Reddy's Labs Q4 result: PAT up 9 times, div declared at Rs 40 per share
✔️ Dr. Reddy's Q4FY23 results: Consolidated PAT at 959 cr, rises by 10-folds YoY; 800% dividend for shareholders
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 13-01-2023 To 10-05-2023
✔️ Dr Reddy's acquires trademark rights for Pfizer breast cancer drug
✔️ Dr. Reddy's buys trademark rights for Primcyvfrom Pfizer for domestic market
✔️ Dr Reddy's reports 77% growth in Q3 consolidated profit
✔️ Dr Reddy's Q3 consolidated profit jumps 77%; what should investors do with the stock?
✔️ Dr Reddy's shares: Should you buy the pharma stock as Q3 net profit rises 77%?
✔️ Dr Reddy's Labs Q4 result: PAT up 9 times, div declared at Rs 40 per share
✔️ Dr. Reddy's Q4FY23 results: Consolidated PAT at 959 cr, rises by 10-folds YoY; 800% dividend for shareholders
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 29-12-2022 To 10-05-2023
✔️ Revlimid: Claims against Dr Reddy's in US court dismissed
✔️ Claims against Dr Reddy's Laboratories over Revlimid in US dismissed
✔️ There's no going back on digitalisation: Satish Reddy of Dr Reddy's Laboratories
✔️ Claims against Dr Reddy's over Revlimid in US dismissed
✔️ Dr Reddy's shares gain after US dismisses claims against Revelimid
✔️ Dr Reddy's Labs Q4 result: PAT up 9 times, div declared at Rs 40 per share
✔️ Dr. Reddy's Q4FY23 results: Consolidated PAT at 959 cr, rises by 10-folds YoY; 800% dividend for shareholders
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 27-12-2022 To 10-05-2023
✔️ Broker's call: Dr Reddy's Laboratories (Buy)
✔️ Claims against Dr Reddy's Laboratories over Revlimid in US dismissed
✔️ There's no going back on digitalisation: Satish Reddy of Dr Reddy's Laboratories
✔️ Claims against Dr Reddy's over Revlimid in US dismissed
✔️ Dr Reddy's shares gain after US dismisses claims against Revelimid
✔️ Dr Reddy's Labs Q4 result: PAT up 9 times, div declared at Rs 40 per share
✔️ Dr. Reddy's Q4FY23 results: Consolidated PAT at 959 cr, rises by 10-folds YoY; 800% dividend for shareholders
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 23-12-2022 To 10-05-2023
✔️ Corbevax maximises protection in Covishield vaccinated people: Study
✔️ Claims against Dr Reddy's Laboratories over Revlimid in US dismissed
✔️ There's no going back on digitalisation: Satish Reddy of Dr Reddy's Laboratories
✔️ Claims against Dr Reddy's over Revlimid in US dismissed
✔️ Dr Reddy's shares gain after US dismisses claims against Revelimid
✔️ Dr Reddy's Labs Q4 result: PAT up 9 times, div declared at Rs 40 per share
✔️ Dr. Reddy's Q4FY23 results: Consolidated PAT at 959 cr, rises by 10-folds YoY; 800% dividend for shareholders
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 22-12-2022 To 10-05-2023
✔️ Buy Dr. Reddy's Laboratories; target of Rs 5460: Sharekhan
✔️ Claims against Dr Reddy's Laboratories over Revlimid in US dismissed
✔️ There's no going back on digitalisation: Satish Reddy of Dr Reddy's Laboratories
✔️ Claims against Dr Reddy's over Revlimid in US dismissed
✔️ Dr Reddy's shares gain after US dismisses claims against Revelimid
✔️ Dr Reddy's Labs Q4 result: PAT up 9 times, div declared at Rs 40 per share
✔️ Dr. Reddy's Q4FY23 results: Consolidated PAT at 959 cr, rises by 10-folds YoY; 800% dividend for shareholders
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 19-12-2022 To 10-05-2023
✔️ Pharma industry needs govt's research-push to scale innovation challenges: Satish Reddy
✔️ Dr Reddy's completes phase 1 study for biosimilar of tocilizumab
✔️ Dr Reddy's completes phase-1 trialsof arthritistocilizumab biosimilar
✔️ Claims against Dr Reddy's over Revlimid in US dismissed
✔️ Dr Reddy's shares gain after US dismisses claims against Revelimid
✔️ Dr Reddy's Labs Q4 result: PAT up 9 times, div declared at Rs 40 per share
✔️ Dr. Reddy's Q4FY23 results: Consolidated PAT at 959 cr, rises by 10-folds YoY; 800% dividend for shareholders
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 16-12-2022 To 10-05-2023
✔️ Dr Reddy's arm haltsdevelopment of oral drug forpsoriasis
✔️ Dr Reddy's completes phase 1 study for biosimilar of tocilizumab
✔️ Dr Reddy's completes phase-1 trialsof arthritistocilizumab biosimilar
✔️ Claims against Dr Reddy's over Revlimid in US dismissed
✔️ Dr Reddy's shares gain after US dismisses claims against Revelimid
✔️ Dr Reddy's Labs Q4 result: PAT up 9 times, div declared at Rs 40 per share
✔️ Dr. Reddy's Q4FY23 results: Consolidated PAT at 959 cr, rises by 10-folds YoY; 800% dividend for shareholders
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 04-12-2022 To 10-05-2023
✔️ Dr Reddy's, Sun Pharma recall products in US for manufacturing issues
✔️ Dr Reddy's, Sun Pharma recall products in US for manufacturing issues
✔️ Dr Reddy's completes phase-1 trialsof arthritistocilizumab biosimilar
✔️ Claims against Dr Reddy's over Revlimid in US dismissed
✔️ Dr Reddy's shares gain after US dismisses claims against Revelimid
✔️ Dr Reddy's Labs Q4 result: PAT up 9 times, div declared at Rs 40 per share
✔️ Dr. Reddy's Q4FY23 results: Consolidated PAT at 959 cr, rises by 10-folds YoY; 800% dividend for shareholders
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 25-11-2022 To 10-05-2023
✔️ About 25% of Dr Reddy's products to be first-to-market by 2027: Co-chairman GV Prasad
✔️ About 25% of Dr. Reddy's product launches to be first-to-market by 2027: Co-chairman GV Prasad
✔️ Dr Reddy's completes phase-1 trialsof arthritistocilizumab biosimilar
✔️ Claims against Dr Reddy's over Revlimid in US dismissed
✔️ Dr Reddy's shares gain after US dismisses claims against Revelimid
✔️ Dr Reddy's Labs Q4 result: PAT up 9 times, div declared at Rs 40 per share
✔️ Dr. Reddy's Q4FY23 results: Consolidated PAT at 959 cr, rises by 10-folds YoY; 800% dividend for shareholders
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 22-11-2022 To 10-05-2023
✔️ Antitrust Litigation Filed Against Dr Reddy's Laboratories In US
✔️ Dr Reddy's faces anti-trustsuit in US court over Revlimid
✔️ Dr Reddy's completes phase-1 trialsof arthritistocilizumab biosimilar
✔️ Claims against Dr Reddy's over Revlimid in US dismissed
✔️ Dr Reddy's shares gain after US dismisses claims against Revelimid
✔️ Dr Reddy's Labs Q4 result: PAT up 9 times, div declared at Rs 40 per share
✔️ Dr. Reddy's Q4FY23 results: Consolidated PAT at 959 cr, rises by 10-folds YoY; 800% dividend for shareholders
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 20-11-2022 To 10-05-2023
✔️ Dr Reddy's is now No.2 drug firm as old order changes
✔️ Dr Reddy's faces anti-trustsuit in US court over Revlimid
✔️ Dr Reddy's completes phase-1 trialsof arthritistocilizumab biosimilar
✔️ Claims against Dr Reddy's over Revlimid in US dismissed
✔️ Dr Reddy's shares gain after US dismisses claims against Revelimid
✔️ Dr Reddy's Labs Q4 result: PAT up 9 times, div declared at Rs 40 per share
✔️ Dr. Reddy's Q4FY23 results: Consolidated PAT at 959 cr, rises by 10-folds YoY; 800% dividend for shareholders
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 06-11-2022 To 10-05-2023
✔️ Dr Reddy's lines up Rs 1,500 cr capex, to focus on biosimilars, injectables
✔️ Dr Reddy's To Earmark Rs 1,500 Crore Capex For Biosimilars, Injectables
✔️ Dr Reddy's completes phase-1 trialsof arthritistocilizumab biosimilar
✔️ Claims against Dr Reddy's over Revlimid in US dismissed
✔️ Dr Reddy's shares gain after US dismisses claims against Revelimid
✔️ Dr Reddy's Labs Q4 result: PAT up 9 times, div declared at Rs 40 per share
✔️ Dr. Reddy's Q4FY23 results: Consolidated PAT at 959 cr, rises by 10-folds YoY; 800% dividend for shareholders
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 01-11-2022 To 10-05-2023
✔️ Buy Dr Reddy's Labs; target of Rs 5180: Motilal Oswal
✔️ Buy Dr Reddy's Laboratories; target of Rs 5215: ICICI Direct
✔️ Buy Dr. Reddy's Laboratories; target of Rs 4900: Prabhudas Lilladher
✔️ Claims against Dr Reddy's over Revlimid in US dismissed
✔️ Dr Reddy's shares gain after US dismisses claims against Revelimid
✔️ Dr Reddy's Labs Q4 result: PAT up 9 times, div declared at Rs 40 per share
✔️ Dr. Reddy's Q4FY23 results: Consolidated PAT at 959 cr, rises by 10-folds YoY; 800% dividend for shareholders
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 31-10-2022 To 10-05-2023
✔️ Results Earnings Call for Q2FY23 of Dr. Reddy's Laboratories Ltd.
✔️ Dr Reddy's surges as Revlimid generic helps drug maker sprint past estimates
✔️ Dr Reddy's 2Q: Key takeaways for investors
✔️ Claims against Dr Reddy's over Revlimid in US dismissed
✔️ Dr Reddy's shares gain after US dismisses claims against Revelimid
✔️ Dr Reddy's Labs Q4 result: PAT up 9 times, div declared at Rs 40 per share
✔️ Dr. Reddy's Q4FY23 results: Consolidated PAT at 959 cr, rises by 10-folds YoY; 800% dividend for shareholders
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 28-10-2022 To 10-05-2023
✔️ Dr Reddys Labs Standalone September 2022 Net Sales at Rs 4,880.30 crore, up 27.64% Y-o-Y
✔️ Dr Reddy's PAT rises 12% at Rs 1,113 cr in Q2
✔️ Dr Reddy's PAT up 12% at Rs 1,113 cr in Q2; revenue rises 9% to Rs 6,305 cr
✔️ Dr Reddy's Q2 profit rises 12% with new generic launches in US market
✔️ Dr Reddy's Q2 net up 12 per cent at Rs 1,113 cr
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 27-10-2022 To 10-05-2023
✔️ Dr Reddy's Q2 preview: Pharma major likely to report sharp drop net profit on weak US biz
✔️ Dr Reddy's PAT rises 12% at Rs 1,113 cr in Q2
✔️ Dr Reddy's PAT up 12% at Rs 1,113 cr in Q2; revenue rises 9% to Rs 6,305 cr
✔️ Dr Reddy's Q2 profit rises 12% with new generic launches in US market
✔️ Dr Reddy's Q2 net up 12 per cent at Rs 1,113 cr
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 23-10-2022 To 10-05-2023
✔️ Dr Reddy's, Cipla, and Aurobindo units recall products in US market
✔️ Dr Reddy's PAT rises 12% at Rs 1,113 cr in Q2
✔️ Dr Reddy's PAT up 12% at Rs 1,113 cr in Q2; revenue rises 9% to Rs 6,305 cr
✔️ Dr Reddy's Q2 profit rises 12% with new generic launches in US market
✔️ Dr Reddy's Q2 net up 12 per cent at Rs 1,113 cr
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 11-10-2022 To 10-05-2023
✔️ WEF recognises Dr. Reddy's Hyderabad unit as part of GLN
✔️ WEF recognises Dr. Reddy's Hyd factory as part of its Global Lighthouse Network
✔️ Dr Reddy's PAT up 12% at Rs 1,113 cr in Q2; revenue rises 9% to Rs 6,305 cr
✔️ Dr Reddy's Q2 profit rises 12% with new generic launches in US market
✔️ Dr Reddy's Q2 net up 12 per cent at Rs 1,113 cr
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 08-09-2022 To 10-05-2023
✔️ Dr. Reddy's launchesgeneric Revlimid capsules in the US
✔️ WEF recognises Dr. Reddy's Hyd factory as part of its Global Lighthouse Network
✔️ Dr Reddy's PAT up 12% at Rs 1,113 cr in Q2; revenue rises 9% to Rs 6,305 cr
✔️ Dr Reddy's Q2 profit rises 12% with new generic launches in US market
✔️ Dr Reddy's Q2 net up 12 per cent at Rs 1,113 cr
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 30-08-2022 To 10-05-2023
✔️ Dr Reddy's, Aurigene ink MoU with DNDi on neglected tropical diseases
✔️ WEF recognises Dr. Reddy's Hyd factory as part of its Global Lighthouse Network
✔️ Dr Reddy's PAT up 12% at Rs 1,113 cr in Q2; revenue rises 9% to Rs 6,305 cr
✔️ Dr Reddy's Q2 profit rises 12% with new generic launches in US market
✔️ Dr Reddy's Q2 net up 12 per cent at Rs 1,113 cr
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 26-08-2022 To 10-05-2023
✔️ Stocks to Watch Today | Dr Reddy's Laboratories, Syrma SGS Technology, Eicher Motors, and others in news today
✔️ WEF recognises Dr. Reddy's Hyd factory as part of its Global Lighthouse Network
✔️ Dr Reddy's PAT up 12% at Rs 1,113 cr in Q2; revenue rises 9% to Rs 6,305 cr
✔️ Dr Reddy's Q2 profit rises 12% with new generic launches in US market
✔️ Dr Reddy's Q2 net up 12 per cent at Rs 1,113 cr
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 19-08-2022 To 10-05-2023
✔️ Intercept Pharmaceuticals settles Ocaliva patent litigation case with Dr Reddy's
✔️ WEF recognises Dr. Reddy's Hyd factory as part of its Global Lighthouse Network
✔️ Dr Reddy's PAT up 12% at Rs 1,113 cr in Q2; revenue rises 9% to Rs 6,305 cr
✔️ Dr Reddy's Q2 profit rises 12% with new generic launches in US market
✔️ Dr Reddy's Q2 net up 12 per cent at Rs 1,113 cr
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 17-08-2022 To 10-05-2023
✔️ At least 8 Indian companies working to develop monkeypox vaccine: Report
✔️ WEF recognises Dr. Reddy's Hyd factory as part of its Global Lighthouse Network
✔️ Dr Reddy's PAT up 12% at Rs 1,113 cr in Q2; revenue rises 9% to Rs 6,305 cr
✔️ Dr Reddy's Q2 profit rises 12% with new generic launches in US market
✔️ Dr Reddy's Q2 net up 12 per cent at Rs 1,113 cr
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 15-08-2022 To 10-05-2023
✔️ Pharma@75: More innovation hubs need to come up in the country, says Satish Reddy
✔️ WEF recognises Dr. Reddy's Hyd factory as part of its Global Lighthouse Network
✔️ Dr Reddy's PAT up 12% at Rs 1,113 cr in Q2; revenue rises 9% to Rs 6,305 cr
✔️ Dr Reddy's Q2 profit rises 12% with new generic launches in US market
✔️ Dr Reddy's Q2 net up 12 per cent at Rs 1,113 cr
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 02-08-2022 To 10-05-2023
✔️ Pharma, financial counters top on traders' chart
✔️ WEF recognises Dr. Reddy's Hyd factory as part of its Global Lighthouse Network
✔️ Dr Reddy's PAT up 12% at Rs 1,113 cr in Q2; revenue rises 9% to Rs 6,305 cr
✔️ Dr Reddy's Q2 profit rises 12% with new generic launches in US market
✔️ Dr Reddy's Q2 net up 12 per cent at Rs 1,113 cr
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 30-07-2022 To 10-05-2023
✔️ Dr Reddy's Laboratories inks licensing pact with US' Slayback Pharma
✔️ Dr Reddy's inkslicensing pactwith Slayback Pharma for Lumify inUS
✔️ Dr Reddy's Q1: Even beyond one-offs, underlying results weak
✔️ Dr Reddy's Q2 profit rises 12% with new generic launches in US market
✔️ Dr Reddy's Q2 net up 12 per cent at Rs 1,113 cr
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 28-07-2022 To 10-05-2023
✔️ Dr Reddy's Q1 net at 1,188 crore, up 108% from Q1-FY21
✔️ Other income pushes Dr Reddy's PAT up 108 per cent at 1,188 Cr in Q1
✔️ Dr Reddy's PAT up 108% at Rs 1,188 crore in Q1
✔️ Dr Reddy's PAT soars 108% at Rs 1,188 crore in Q1; revenue rises 6%
✔️ Dr Reddy's Q2 net up 12 per cent at Rs 1,113 cr
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 27-07-2022 To 10-05-2023
✔️ Dr Reddy's Q1 revenue may grow up to 10% YoY, margins may expand: Analysts
✔️ Dr Reddy's launches genericBortezomib injection in US
✔️ Dr Reddy's PAT up 108% at Rs 1,188 crore in Q1
✔️ Dr Reddy's PAT soars 108% at Rs 1,188 crore in Q1; revenue rises 6%
✔️ Dr Reddy's Q2 net up 12 per cent at Rs 1,113 cr
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 22-07-2022 To 10-05-2023
✔️ Dr Reddy's launches new product in US
✔️ Dr Reddy's launches new product in US
✔️ Dr Reddy's launches generic version of Allegra in US
✔️ Dr Reddy's PAT soars 108% at Rs 1,188 crore in Q1; revenue rises 6%
✔️ Dr Reddy's Q2 net up 12 per cent at Rs 1,113 cr
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 11-07-2022 To 10-05-2023
✔️ Dr Reddy's gains over 3% on new drug launch in the US market
✔️ Dr Reddy's launches new product in US
✔️ Dr Reddy's launches generic version of Allegra in US
✔️ Dr Reddy's PAT soars 108% at Rs 1,188 crore in Q1; revenue rises 6%
✔️ Dr Reddy's Q2 net up 12 per cent at Rs 1,113 cr
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 08-07-2022 To 10-05-2023
✔️ Dr Reddy's launches Fesoterodine Fumarate tablets in US
✔️ Dr Reddy's launches Fesoterodine Fumarate tablets in US
✔️ Dr Reddy's launches generic version of Allegra in US
✔️ Dr Reddy's PAT soars 108% at Rs 1,188 crore in Q1; revenue rises 6%
✔️ Dr Reddy's Q2 net up 12 per cent at Rs 1,113 cr
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 07-07-2022 To 10-05-2023
✔️ Andhra plant gets two observations from USFDA: Dr Reddy's Laboratories
✔️ Dr Reddy's Lab says its Andhra plant gets two observations from USFDA
✔️ Dr Reddy's launches generic version of Allegra in US
✔️ Dr Reddy's PAT soars 108% at Rs 1,188 crore in Q1; revenue rises 6%
✔️ Dr Reddy's Q2 net up 12 per cent at Rs 1,113 cr
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 06-07-2022 To 10-05-2023
✔️ Dr Reddy's says it aims to triple reach to 1.5 bn patients by 2030
✔️ Dr Reddy's aims to triple its reach to 1.5 billion patients by 2030
✔️ Dr Reddy's launches generic version of Allegra in US
✔️ Dr Reddy's PAT soars 108% at Rs 1,188 crore in Q1; revenue rises 6%
✔️ Dr Reddy's Q2 net up 12 per cent at Rs 1,113 cr
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 01-07-2022 To 10-05-2023
✔️ JB Pharma acquires four brands from Dr Reddy's Laboratories for 98.3 crore
✔️ Dr Reddy's aims to triple its reach to 1.5 billion patients by 2030
✔️ Dr Reddy's launches generic version of Allegra in US
✔️ Dr Reddy's PAT soars 108% at Rs 1,188 crore in Q1; revenue rises 6%
✔️ Dr Reddy's Q2 net up 12 per cent at Rs 1,113 cr
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 30-06-2022 To 10-05-2023
✔️ JB Chemicals gets board approval to acquire Dr Reddy's 4 brands for 98 cr
✔️ Dr Reddy's settles patent litigation with Indivior, Aquestive Therapeutics
✔️ Dr Reddy's launches generic version of Allegra in US
✔️ Dr Reddy's PAT soars 108% at Rs 1,188 crore in Q1; revenue rises 6%
✔️ Dr Reddy's Q2 net up 12 per cent at Rs 1,113 cr
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 28-06-2022 To 10-05-2023
✔️ Investor Day Transcript: Dr. Reddy's Laboratories
✔️ Dr Reddy's settles patent litigation with Indivior, Aquestive Therapeutics
✔️ Dr Reddy's launches generic version of Allegra in US
✔️ Dr Reddy's PAT soars 108% at Rs 1,188 crore in Q1; revenue rises 6%
✔️ Dr Reddy's Q2 net up 12 per cent at Rs 1,113 cr
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 24-06-2022 To 10-05-2023
✔️ Dr Reddy's settles therapeutic drug patent litigation with Indivior, Aquestive Therapeutics
✔️ Dr Reddy's acquire Eton Pharma's injectable products for $50 million
✔️ Dr Reddy's buys injectable product portfolio from Eton Pharmaceuticals for $50 m
✔️ Dr Reddy's Lab inks settlement pact with Indivior, Aquestive
✔️ Dr Reddy's to acquire injectable product portfolio from Eton Pharma for $50 mn
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 22-06-2022 To 10-05-2023
✔️ 3 stocks to buy, accumulate with potential upside of up to 50%
✔️ Dr Reddy's acquire Eton Pharma's injectable products for $50 million
✔️ Dr Reddy's buys injectable product portfolio from Eton Pharmaceuticals for $50 m
✔️ Dr Reddy's Lab inks settlement pact with Indivior, Aquestive
✔️ Dr Reddy's to acquire injectable product portfolio from Eton Pharma for $50 mn
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 16-06-2022 To 10-05-2023
✔️ LIC increases stake in Dr Reddy's
✔️ LIC ups stake in Dr Reddy's to 5.6 per cent
✔️ Dr Reddy's buys injectable product portfolio from Eton Pharmaceuticals for $50 m
✔️ Dr Reddy's Lab inks settlement pact with Indivior, Aquestive
✔️ Dr Reddy's to acquire injectable product portfolio from Eton Pharma for $50 mn
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 14-06-2022 To 10-05-2023
✔️ Dr. Reddy's launches Nexavar generic in the US
✔️ LIC ups stake in Dr Reddy's to 5.6 per cent
✔️ Dr Reddy's buys injectable product portfolio from Eton Pharmaceuticals for $50 m
✔️ Dr Reddy's Lab inks settlement pact with Indivior, Aquestive
✔️ Dr Reddy's to acquire injectable product portfolio from Eton Pharma for $50 mn
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 13-06-2022 To 10-05-2023
✔️ Top 10 trading ideas from experts for next 3-4 weeks as bears maul the markets
✔️ LIC ups stake in Dr Reddy's to 5.6 per cent
✔️ Dr Reddy's buys injectable product portfolio from Eton Pharmaceuticals for $50 m
✔️ Dr Reddy's Lab inks settlement pact with Indivior, Aquestive
✔️ Dr Reddy's to acquire injectable product portfolio from Eton Pharma for $50 mn
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 10-06-2022 To 10-05-2023
✔️ Dr Reddy's arm inks pact with US-based Olema Pharmaceuticals
✔️ Dr Reddy's subsidiary inks pact with US-based Olema Pharmaceuticals
✔️ Dr Reddy's buys injectable product portfolio from Eton Pharmaceuticals for $50 m
✔️ Dr Reddy's Lab inks settlement pact with Indivior, Aquestive
✔️ Dr Reddy's to acquire injectable product portfolio from Eton Pharma for $50 mn
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 07-06-2022 To 10-05-2023
✔️ Why the fall in Dr Reddy's stock today is unwarranted
✔️ Dr Reddy's subsidiary inks pact with US-based Olema Pharmaceuticals
✔️ Dr Reddy's buys injectable product portfolio from Eton Pharmaceuticals for $50 m
✔️ Dr Reddy's Lab inks settlement pact with Indivior, Aquestive
✔️ Dr Reddy's to acquire injectable product portfolio from Eton Pharma for $50 mn
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 28-05-2022 To 10-05-2023
✔️ Dr Reddy's launches Pemetrexed injection in US
✔️ Dr Reddy's subsidiary inks pact with US-based Olema Pharmaceuticals
✔️ Dr Reddy's buys injectable product portfolio from Eton Pharmaceuticals for $50 m
✔️ Dr Reddy's Lab inks settlement pact with Indivior, Aquestive
✔️ Dr Reddy's to acquire injectable product portfolio from Eton Pharma for $50 mn
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 25-05-2022 To 10-05-2023
✔️ Dr. Reddy's, Senores Pharmaceuticals launch Ketorolac Tromethamine tablets in US
✔️ Dr Reddy's subsidiary inks pact with US-based Olema Pharmaceuticals
✔️ Dr Reddy's buys injectable product portfolio from Eton Pharmaceuticals for $50 m
✔️ Dr Reddy's Lab inks settlement pact with Indivior, Aquestive
✔️ Dr Reddy's to acquire injectable product portfolio from Eton Pharma for $50 mn
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 24-05-2022 To 10-05-2023
✔️ Buy Dr. Reddy's Laboratories; target of Rs 5261: KR Choksey
✔️ Dr Reddy's subsidiary inks pact with US-based Olema Pharmaceuticals
✔️ Dr Reddy's buys injectable product portfolio from Eton Pharmaceuticals for $50 m
✔️ Dr Reddy's Lab inks settlement pact with Indivior, Aquestive
✔️ Dr Reddy's to acquire injectable product portfolio from Eton Pharma for $50 mn
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 22-05-2022 To 10-05-2023
✔️ Launches, base biz expansion tonic for Dr Reddy's double-digit growth
✔️ Dr Reddy's subsidiary inks pact with US-based Olema Pharmaceuticals
✔️ Dr Reddy's buys injectable product portfolio from Eton Pharmaceuticals for $50 m
✔️ Dr Reddy's Lab inks settlement pact with Indivior, Aquestive
✔️ Dr Reddy's to acquire injectable product portfolio from Eton Pharma for $50 mn
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 21-05-2022 To 10-05-2023
✔️ Buy Dr Reddy's Laboratories; target of Rs 4800: ICICI Direct
✔️ Buy Dr. Reddy's Laboratories: target of Rs 5550: Sharekhan
✔️ Buy Dr Reddy's Labs; target of Rs 4800: Motilal Oswal
✔️ Dr Reddy's Lab inks settlement pact with Indivior, Aquestive
✔️ Dr Reddy's to acquire injectable product portfolio from Eton Pharma for $50 mn
✔️ Dr Reddy's Lab posts 12% yoy growth in Q2 PAT to 1,113 cr, gross margins expand
✔️ Dr Reddy's Q2 result | Consolidated PAT grows 12 % YoY to Rs 1,113 crore
✔️ Dr Reddy's Q4 net profit jumps to Rs 959 crore on favourable base, US launches, brand deals
✔️ Dr Reddy's likely to post 20-22% growth in Q4 net
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 20-05-2022 To 10-05-2023
✔️ Dr Reddy's sees sharpest intra-day rally since Sept 2020; stock surges 8%
✔️ As Dr Reddy's rises after earnings, should you buy or sell stock?
✔️ Dr Reddy'sQ4 net down 76% at 88 crore
✔️ Dr Reddy's Lab to approach regulator for Sputnik Light as booster dose
✔️ Dr Reddy's Labs Q4 PAT falls 76% on pricing pressure, low export benefit
✔️ Dr Reddy'sQ4 net profit down 76% at 88 crore
✔️ Impairment hit: Dr Reddy's net profit declines 76% to Rs 88 cr in Q4
✔️ Dr Reddy's Q4 PAT falls 76% YoY on impairment costs; misses estimates
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 19-05-2022 To 10-05-2023
✔️ Q4FY22 Quarterly Result Announced for Dr. Reddy's Laboratories Ltd.
✔️ As Dr Reddy's rises after earnings, should you buy or sell stock?
✔️ Dr Reddy'sQ4 net down 76% at 88 crore
✔️ Dr Reddy's Lab to approach regulator for Sputnik Light as booster dose
✔️ Dr Reddy's Labs Q4 PAT falls 76% on pricing pressure, low export benefit
✔️ Dr Reddy'sQ4 net profit down 76% at 88 crore
✔️ Impairment hit: Dr Reddy's net profit declines 76% to Rs 88 cr in Q4
✔️ Dr Reddy's Q4 PAT falls 76% YoY on impairment costs; misses estimates
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 11-05-2022 To 10-05-2023
✔️ Dr Reddy's inks pact with South Korean drug firm HK inno.N Corporation
✔️ Dr. Reddy's, South Korean firm partner for gastric diseases drug
✔️ Dr Reddy'sQ4 net down 76% at 88 crore
✔️ Dr Reddy's Lab to approach regulator for Sputnik Light as booster dose
✔️ Dr Reddy's Labs Q4 PAT falls 76% on pricing pressure, low export benefit
✔️ Dr Reddy'sQ4 net profit down 76% at 88 crore
✔️ Impairment hit: Dr Reddy's net profit declines 76% to Rs 88 cr in Q4
✔️ Dr Reddy's Q4 PAT falls 76% YoY on impairment costs; misses estimates
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 21-04-2022 To 10-05-2023
✔️ Dr Reddy's launchesPosaconazoletablets in US
✔️ Dr. Reddy's, South Korean firm partner for gastric diseases drug
✔️ Dr Reddy'sQ4 net down 76% at 88 crore
✔️ Dr Reddy's Lab to approach regulator for Sputnik Light as booster dose
✔️ Dr Reddy's Labs Q4 PAT falls 76% on pricing pressure, low export benefit
✔️ Dr Reddy'sQ4 net profit down 76% at 88 crore
✔️ Impairment hit: Dr Reddy's net profit declines 76% to Rs 88 cr in Q4
✔️ Dr Reddy's Q4 PAT falls 76% YoY on impairment costs; misses estimates
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 12-04-2022 To 10-05-2023
✔️ Buy Dr. Reddy's Laboratories: target of Rs 5550: Sharekhan
✔️ Dr. Reddy's, South Korean firm partner for gastric diseases drug
✔️ Dr Reddy'sQ4 net down 76% at 88 crore
✔️ Dr Reddy's Lab to approach regulator for Sputnik Light as booster dose
✔️ Dr Reddy's Labs Q4 PAT falls 76% on pricing pressure, low export benefit
✔️ Dr Reddy'sQ4 net profit down 76% at 88 crore
✔️ Impairment hit: Dr Reddy's net profit declines 76% to Rs 88 cr in Q4
✔️ Dr Reddy's Q4 PAT falls 76% YoY on impairment costs; misses estimates
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 05-04-2022 To 10-05-2023
✔️ Dr Reddy's launches new generic injection in US market
✔️ Dr Reddy's launches generic Methylprednisolone Sodium Succinate for injection in US
✔️ Dr Reddy'sQ4 net down 76% at 88 crore
✔️ Dr Reddy's Lab to approach regulator for Sputnik Light as booster dose
✔️ Dr Reddy's Labs Q4 PAT falls 76% on pricing pressure, low export benefit
✔️ Dr Reddy'sQ4 net profit down 76% at 88 crore
✔️ Impairment hit: Dr Reddy's net profit declines 76% to Rs 88 cr in Q4
✔️ Dr Reddy's Q4 PAT falls 76% YoY on impairment costs; misses estimates
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 01-04-2022 To 10-05-2023
✔️ Dr Reddy inks $61-mn deal to acquire Cidmus brand in India from Novartis
✔️ Dr Reddy's launches generic Methylprednisolone Sodium Succinate for injection in US
✔️ Dr Reddy'sQ4 net down 76% at 88 crore
✔️ Dr Reddy's Lab to approach regulator for Sputnik Light as booster dose
✔️ Dr Reddy's Labs Q4 PAT falls 76% on pricing pressure, low export benefit
✔️ Dr Reddy'sQ4 net profit down 76% at 88 crore
✔️ Impairment hit: Dr Reddy's net profit declines 76% to Rs 88 cr in Q4
✔️ Dr Reddy's Q4 PAT falls 76% YoY on impairment costs; misses estimates
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 01-03-2022 To 10-05-2023
✔️ Valuations turning attractive for Dr Reddy's as company outperforms sector
✔️ Dr Reddy's launches generic Methylprednisolone Sodium Succinate for injection in US
✔️ Dr Reddy'sQ4 net down 76% at 88 crore
✔️ Dr Reddy's Lab to approach regulator for Sputnik Light as booster dose
✔️ Dr Reddy's Labs Q4 PAT falls 76% on pricing pressure, low export benefit
✔️ Dr Reddy'sQ4 net profit down 76% at 88 crore
✔️ Impairment hit: Dr Reddy's net profit declines 76% to Rs 88 cr in Q4
✔️ Dr Reddy's Q4 PAT falls 76% YoY on impairment costs; misses estimates
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 24-02-2022 To 10-05-2023
✔️ Dr Reddy's falls 3%, hits 52-week low; stock slips 10% in one month
✔️ Dr Reddy's launches generic Methylprednisolone Sodium Succinate for injection in US
✔️ Dr Reddy'sQ4 net down 76% at 88 crore
✔️ Dr Reddy's Lab to approach regulator for Sputnik Light as booster dose
✔️ Dr Reddy's Labs Q4 PAT falls 76% on pricing pressure, low export benefit
✔️ Dr Reddy'sQ4 net profit down 76% at 88 crore
✔️ Impairment hit: Dr Reddy's net profit declines 76% to Rs 88 cr in Q4
✔️ Dr Reddy's Q4 PAT falls 76% YoY on impairment costs; misses estimates
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 21-02-2022 To 10-05-2023
✔️ Binnopharm to acquire 2 anti-bacterial brands from Dr Reddy's
✔️ Dr Reddy's Laboratories gains 2% on selling of two anti-bacterial brands
✔️ Dr Reddy'sQ4 net down 76% at 88 crore
✔️ Dr Reddy's Lab to approach regulator for Sputnik Light as booster dose
✔️ Dr Reddy's Labs Q4 PAT falls 76% on pricing pressure, low export benefit
✔️ Dr Reddy'sQ4 net profit down 76% at 88 crore
✔️ Impairment hit: Dr Reddy's net profit declines 76% to Rs 88 cr in Q4
✔️ Dr Reddy's Q4 PAT falls 76% YoY on impairment costs; misses estimates
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 16-02-2022 To 10-05-2023
✔️ Mankind Pharma acquires two derma and respiratory brands from Dr Reddy's
✔️ Mankind Pharma to acquire Combihale and Daffy brands from Dr Reddy's Labs
✔️ Mankind Pharma to acquire two brands from Dr Reddy's Laboratories
✔️ Dr Reddy's Lab to approach regulator for Sputnik Light as booster dose
✔️ Dr Reddy's Labs Q4 PAT falls 76% on pricing pressure, low export benefit
✔️ Dr Reddy'sQ4 net profit down 76% at 88 crore
✔️ Impairment hit: Dr Reddy's net profit declines 76% to Rs 88 cr in Q4
✔️ Dr Reddy's Q4 PAT falls 76% YoY on impairment costs; misses estimates
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 11-02-2022 To 10-05-2023
✔️ Dr Reddy's Laboratories inks exclusive sales pact with Novartis India
✔️ Mankind Pharma to acquire Combihale and Daffy brands from Dr Reddy's Labs
✔️ Mankind Pharma to acquire two brands from Dr Reddy's Laboratories
✔️ Dr Reddy's Lab to approach regulator for Sputnik Light as booster dose
✔️ Dr Reddy's Labs Q4 PAT falls 76% on pricing pressure, low export benefit
✔️ Dr Reddy'sQ4 net profit down 76% at 88 crore
✔️ Impairment hit: Dr Reddy's net profit declines 76% to Rs 88 cr in Q4
✔️ Dr Reddy's Q4 PAT falls 76% YoY on impairment costs; misses estimates
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 09-02-2022 To 10-05-2023
✔️ Dr Reddy's Laboratories launches generic drug in the US market
✔️ Mankind Pharma to acquire Combihale and Daffy brands from Dr Reddy's Labs
✔️ Mankind Pharma to acquire two brands from Dr Reddy's Laboratories
✔️ Dr Reddy's Lab to approach regulator for Sputnik Light as booster dose
✔️ Dr Reddy's Labs Q4 PAT falls 76% on pricing pressure, low export benefit
✔️ Dr Reddy'sQ4 net profit down 76% at 88 crore
✔️ Impairment hit: Dr Reddy's net profit declines 76% to Rs 88 cr in Q4
✔️ Dr Reddy's Q4 PAT falls 76% YoY on impairment costs; misses estimates
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 08-02-2022 To 10-05-2023
✔️ Covid-19 vaccine: Hospitals see no immediate rush for Sputnik Light
✔️ Mankind Pharma to acquire Combihale and Daffy brands from Dr Reddy's Labs
✔️ Mankind Pharma to acquire two brands from Dr Reddy's Laboratories
✔️ Dr Reddy's Lab to approach regulator for Sputnik Light as booster dose
✔️ Dr Reddy's Labs Q4 PAT falls 76% on pricing pressure, low export benefit
✔️ Dr Reddy'sQ4 net profit down 76% at 88 crore
✔️ Impairment hit: Dr Reddy's net profit declines 76% to Rs 88 cr in Q4
✔️ Dr Reddy's Q4 PAT falls 76% YoY on impairment costs; misses estimates
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 06-02-2022 To 10-05-2023
✔️ Submitted proposal to test Sputnik Light as Covid booster dose: Dr Reddy's
✔️ Mankind Pharma to acquire Combihale and Daffy brands from Dr Reddy's Labs
✔️ Mankind Pharma to acquire two brands from Dr Reddy's Laboratories
✔️ Dr Reddy's Lab to approach regulator for Sputnik Light as booster dose
✔️ Dr Reddy's Labs Q4 PAT falls 76% on pricing pressure, low export benefit
✔️ Dr Reddy'sQ4 net profit down 76% at 88 crore
✔️ Impairment hit: Dr Reddy's net profit declines 76% to Rs 88 cr in Q4
✔️ Dr Reddy's Q4 PAT falls 76% YoY on impairment costs; misses estimates
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 03-02-2022 To 10-05-2023
✔️ Dr Reddy's Laboratories inks agreement to acquire Nimbus Health GmbH
✔️ Dr Reddy's to acquire German medical cannabis firm Nimbus Health
✔️ Mankind Pharma to acquire two brands from Dr Reddy's Laboratories
✔️ Dr Reddy's Lab to approach regulator for Sputnik Light as booster dose
✔️ Dr Reddy's Labs Q4 PAT falls 76% on pricing pressure, low export benefit
✔️ Dr Reddy'sQ4 net profit down 76% at 88 crore
✔️ Impairment hit: Dr Reddy's net profit declines 76% to Rs 88 cr in Q4
✔️ Dr Reddy's Q4 PAT falls 76% YoY on impairment costs; misses estimates
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 01-02-2022 To 10-05-2023
✔️ Buy Dr Reddy's Labs; target of Rs 5160: Motilal Oswal
✔️ Buy Dr Reddys Laboratories; target of Rs 5160: ICICI Direct
✔️ Mankind Pharma to acquire two brands from Dr Reddy's Laboratories
✔️ Dr Reddy's Lab to approach regulator for Sputnik Light as booster dose
✔️ Dr Reddy's Labs Q4 PAT falls 76% on pricing pressure, low export benefit
✔️ Dr Reddy'sQ4 net profit down 76% at 88 crore
✔️ Impairment hit: Dr Reddy's net profit declines 76% to Rs 88 cr in Q4
✔️ Dr Reddy's Q4 PAT falls 76% YoY on impairment costs; misses estimates
✔️ Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
✔️ Dr Reddy's shares trades flat on Wednesday's early session ahead of Q4 numbers; check details
✔️ Dr Reddy Share Price Live blog for 10 May 2023
-: Stock News :- DRREDDY 30-05-2023 To 30-05-2023
✔️ Dr Reddy Share Price Live blog for 30 May 2023
-: Stock News :- DRREDDY 29-05-2023 To 29-05-2023
✔️ Dr Reddy Share Price Live blog for 29 May 2023
-: Stock News :- DRREDDY 26-05-2023 To 26-05-2023
✔️ Dr Reddy Share Price Live blog for 26 May 2023
-: Stock News :- DRREDDY 25-05-2023 To 25-05-2023
✔️ Dr Reddy Share Price Live blog for 25 May 2023
-: Stock News :- DRREDDY 24-05-2023 To 24-05-2023
✔️ Dr Reddy Share Price Live blog for 24 May 2023
-: Stock News :- DRREDDY 23-05-2023 To 23-05-2023
✔️ Dr Reddy Share Price Live blog for 23 May 2023
-: Stock News :- DRREDDY 22-05-2023 To 22-05-2023
✔️ Dr Reddy Share Price Live blog for 22 May 2023
-: Stock News :- DRREDDY 19-05-2023 To 19-05-2023
✔️ Dr Reddy Share Price Live blog for 19 May 2023
-: Stock News :- DRREDDY 18-05-2023 To 18-05-2023
✔️ Hold Dr. Reddy's Laboratories; target of Rs 5100: Sharekhan
-: Stock News :- DRREDDY 18-05-2023 To 17-05-2023
✔️ Dr Reddy Share Price Live blog for 18 May 2023
✔️ Pharma major Dr Reddy's says pipeline of complex drugs to drive revenue growth in next 4-5 years
✔️ Dr Reddy Share Price Live blog for 17 May 2023
-: Stock News :- DRREDDY 09-06-2023 To 09-06-2023
✔️ Dr Reddy Share Price Live blog for 09 Jun 2023
-: Stock News :- DRREDDY 08-06-2023 To 08-06-2023
✔️ Dr Reddy Share Price Live blog for 08 Jun 2023
-: Stock News :- DRREDDY 06-06-2023 To 06-06-2023
✔️ Dr Reddy Share Price Live blog for 06 Jun 2023
-: Stock News :- DRREDDY 05-06-2023 To 05-06-2023
✔️ Dr Reddy's completes Phase-I study in proposed biosimilar of tocilizumab
✔️ Dr Reddy's successfully completes phase-1 study oftocilizumab biosimilar
✔️ Dr Reddy's shares gain after Phase I study of antirheumatic biosimilar ends
-: Stock News :- DRREDDY 02-06-2023 To 05-06-2023
✔️ Dr Reddy Share Price Live blog for 02 Jun 2023
✔️ Dr Reddy's successfully completes phase-1 study oftocilizumab biosimilar
✔️ Dr Reddy's shares gain after Phase I study of antirheumatic biosimilar ends
-: Stock News :- DRREDDY 31-05-2023 To 05-06-2023
✔️ Dr Reddy Share Price Live blog for 31 May 2023
✔️ Dr Reddy's successfully completes phase-1 study oftocilizumab biosimilar
✔️ Dr Reddy's shares gain after Phase I study of antirheumatic biosimilar ends
-: Stock News :- DRREDDY 30-05-2023 To 05-06-2023
✔️ Dr Reddy Share Price Live blog for 30 May 2023
✔️ Dr Reddy's successfully completes phase-1 study oftocilizumab biosimilar
✔️ Dr Reddy's shares gain after Phase I study of antirheumatic biosimilar ends
-: Stock News :- DRREDDY 29-05-2023 To 05-06-2023
✔️ Dr Reddy Share Price Live blog for 29 May 2023
✔️ Dr Reddy's successfully completes phase-1 study oftocilizumab biosimilar
✔️ Dr Reddy's shares gain after Phase I study of antirheumatic biosimilar ends
-: Stock News :- DRREDDY 26-05-2023 To 05-06-2023
✔️ Dr Reddy Share Price Live blog for 26 May 2023
✔️ Dr Reddy's successfully completes phase-1 study oftocilizumab biosimilar
✔️ Dr Reddy's shares gain after Phase I study of antirheumatic biosimilar ends
-: Stock News :- DRREDDY 25-05-2023 To 05-06-2023
✔️ Dr Reddy Share Price Live blog for 25 May 2023
✔️ Dr Reddy's successfully completes phase-1 study oftocilizumab biosimilar
✔️ Dr Reddy's shares gain after Phase I study of antirheumatic biosimilar ends
-: Stock News :- DRREDDY 24-05-2023 To 05-06-2023
✔️ Dr Reddy Share Price Live blog for 24 May 2023
✔️ Dr Reddy's successfully completes phase-1 study oftocilizumab biosimilar
✔️ Dr Reddy's shares gain after Phase I study of antirheumatic biosimilar ends
-: Stock News :- DRREDDY 23-05-2023 To 05-06-2023
✔️ Dr Reddy Share Price Live blog for 23 May 2023
✔️ Dr Reddy's successfully completes phase-1 study oftocilizumab biosimilar
✔️ Dr Reddy's shares gain after Phase I study of antirheumatic biosimilar ends
-: Stock News :- DRREDDY 22-05-2023 To 05-06-2023
✔️ Dr Reddy Share Price Live blog for 22 May 2023
✔️ Dr Reddy's successfully completes phase-1 study oftocilizumab biosimilar
✔️ Dr Reddy's shares gain after Phase I study of antirheumatic biosimilar ends
-: Stock News :- DRREDDY 19-05-2023 To 05-06-2023
✔️ Dr Reddy Share Price Live blog for 19 May 2023
✔️ Dr Reddy's successfully completes phase-1 study oftocilizumab biosimilar
✔️ Dr Reddy's shares gain after Phase I study of antirheumatic biosimilar ends
-: Stock News :- DRREDDY 18-05-2023 To 05-06-2023
✔️ Hold Dr. Reddy's Laboratories; target of Rs 5100: Sharekhan
✔️ Dr Reddy's successfully completes phase-1 study oftocilizumab biosimilar
✔️ Dr Reddy's shares gain after Phase I study of antirheumatic biosimilar ends
No More Records...